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ABSTRACT 
Babbs, Charles Frederick, Ph.D., Drug Induced Changes in 
Ventricular Defibrillation Threshold, December 1977. 
Major Professors: G.K.W. Yim and L.A. Geddes. 
A theory is developed that the minimal current required 
for electrical ventricular defibrillation (the defibrilla-
tion threshold) is proportional to the gap between the 
resting transmembrane potential and the threshold trans-
membrane potential of myocardial cells. This voltage gap 
is, in turn, related to the sodium conductance (gNa) 
and the potassium conductance (gK) of the membrane and to 
the transmembrane equilibrium potentials for sodium (ENa) 
and potassium (EK) . To test the theory pharmacologic 
studies were performed. First, the stability and precision 
of control data and, second, the effect upon defibrillation 
threshold of quinidine (which alters gNa), lidocaine (which 
alters gK), and potassium chloride (which alters EK) were 
evaluated in pentobarbital-anesthetized dogs. Threshold 
was determined by repeated trials of fibrillation and de-
fibrillation with successive damped sinusoidal shocks of 
diminishing current intensity, each 10 percent less than 
the preceding shock. The lowest shock intensity that de-
fibrillated was defined as threshold. 
viii 
Threshold current and energy in five dogs averaged 2 
percent and 13 percent less,~~Sfectively,under surgical levels 
of pentobarbital anesthesia than thresholds in the same 
animals in the awake, unanesthetized state. In dogs given 
sufficient pentobarbital to produce apnea and supported by 
mechanical ventilation, threshold current and energy ave-
raged 3 percent and 17 percent less than comparable awake 
values. These differences were not statistically signifi-
cant. Pentobarbital was consequently selected as the 
anesthetic for defibrillation studies. 
Over 200 measurements of ventricular defibrillation 
threshold were made to determine the stability and 
precision of threshold data. In three groups of five dogs 
each, threshold was measured at intervals of 60, 15, and 
5 minutes over periods of 8, 5, and 1 hour, respectively. 
Similar results were obtained for all groups. There was 
no significant change in mean threshold current with time. 
Due to a decrease in transchest impedance, threshold 
delivered energy decreased by 10 percent during the first 
hour of testing. Standard deviations for threshold peak 
current and delivered energy in a given animal were 11 and 





averaged 7.38, 34 mmHg, and 72 mmHg, 
respectively. The rates of change of pH, pco 2 , and po2 
were not significantly different from zero. Ventricular 
defibrillation threshold is therefore a stable 
ix 
physiologic parameter which may be measured with 
reasonable precision for pharmacologic studies. 
Drug effects on threshold delivered energy and peak 
current, expressed as percentages of pre-drug threshold, 
are given in the table. Table entries indicate maximal 
changes in mean defibrillation threshold. 
Treatment 
Quinidine (50 mg/kg, i.v.) 
Lidocaine (3 mg/kg, i.v.) 
Lidocaine ( 0. 5 mg/kg/min i. v. , 
40 mg/kg total dose) 
Elevation of plasma K to 
7.5 mEq/1 by KCl infusion 
Elevation of plasma K to 16.6 
mEq/1 by KCl infusion 

















Observed drug effects are consistent with theoretical 
predictions that drugs \vhich decrease gNa or increase gK 
increase defibrillation threshold and drugs which make EK 
less negative decrease defibrillation threshold. 
CHAPTER 1 
BACKGROUND AND THEORY 
Statement of the Problem 
The studies described in this thesis were conducted 
1 
to determine the manner in which selected drugs influence 
the electric shock intensity required for ventricular 
defibrillation. Electrical defibrillation, the application 
of a strong electric shock to the heart, is the only safe 
and effective therapy for ventricular fibrillation, an 
otherwise lethal cardiac rhythm. In theory, the passage 
of an electric shock on the order of 100 ma/cm2 through 
the ventricules for 2-30 msec will simultaneously 
stimulate most ventricular muscle cells, causing poten-
tially excitable cells to be refractory for a brief 
interval thereafter. This intervention stops the self-
propagation of the multiple random waves of excitation 
which constitute fibrillation. The minimum shock intensity 
required to produce defibrillation is defined as the 
"defibrillation threshold." In Chapter 1 of this thesis 
a theory is developed which states that defibrillation 
threshold is determined by the difference between the 
resting transmembrane electrical potential and the 
firing or threshold potential of individual myocardial 
cells. Drugs which act at the cellular level to narrow 
2 
the gap between the resting potential and firing potential 
of working myocardial cells would be expected to decrease 
the electrical defibrillation threshold. Obversely, drugs 
which widen this gap would be expected to increase 
defibrillation threshold. Further theoretical analysis 
based upon fundamental principles of membrane physiology 
indicates that drugs which alter the sodium or potassium 
conductance of cell membranes, or the ratio of intracellular 
to extracellular sodium or potassium concentration should 
alter the difference between the resting potential and 
firing potential of cardiac cells and in turn alter the 
defibrillation threshold. 
The present research, therefore, includes three 
aspects: first, development of a theory which predicts in 
a semiquantitative fashion the electrical shock intensity 
for defibrillation and the possible mechanisms by which 
drug treatments could alter the threshold; second, the 
development of a suitable animal model for experimental 
investigation of drug effects on ventricular defibrillation 
threshold; and third, the comparison of experimentally 
produced drug effects with theoretical predictions. 
Chapters 1, 2, and 3 deal respectively with these aspects 
of the problem. 
3 
Mechanisms of Fibrillation 
Ventricular fibrillation, the most dangerous cardiac 
arrhythmia, is a common immediate cause of death in 
patients with heart, lung, or kidney disease. During this 
arrhythmia, there is random, uncoordinated contraction of 
multiple areas of muscle in the cardiac ventricles. When 
viewed directly, the heart appears as a shimmering mass of 
tissue. Upon close inspection multiple, unsynchronized 
waves of contraction and relaxation can be seen traversing 
the ventricular surface in random directions. As a result 
of this arrhythmia no blood is pumped and circulation to 
the brain, the heart itself, and other vital organs comes 
to a standstill. Ventricular fibrillation causes certain 
death if resuscitative measures and definitive therapy are 
not begun within three to five minutes {Stephenson, 1974). 
Circulation adequate to sustain life may be maintained for 
up to several hours by massage of the fibrillating ventri-
cles, using open or closed chest techniques in conjunction 
with artificial ventilation. However, spontaneous de-
fibrillation of the ventricles virtually never occurs in 
humans. 
The Circus Motion Theory 
The simplest theory describing a mechanism for ventri-
cular fibrillation is the circus motion theory of Garrey 
{1914). Development of a "circus motion" may be demon-
strated in rings of myocardium such as those illustrated 
4 
in Figure 1-1. Such rings were created by Mines (1913) 
by cutting the atria of the ray fish and by Garrey (1914) 
by cutting the turtle ventricle. Such a ring of mammalian 
ventricle is normally excited by Purkinje fibers which first 
stimulate subendocardial muscle fibers. The impulse then 
spreads from subendocardial muscle to the epicardial 
surface (Figure 1-l(a)). Further spread of the impulse is 
impossible because ventricular muscle is refractory for 
about 300 msec. Hence such a normally conducted impulse 
cannot become self-propagating. 
A typical premature ventricular contraction (PVC) is 
likewise not self-propagating. An impulse arising from a 
single focus in the ventricular wall and spreading in all 
directions will coalesce on the side of the heart opposite 
its origin and annihilate itself due to the refractoriness 
of the converging masses of recently excited tissue 
(Figure 1-1 (~J)) • 
In injured hearts containing patchy areas of re-
fractoriness during early diastole, however, PVCs are 
more dangerous. In Figure 1-l(c) an impulse arising from 
an irritable focus at the edge of an injured area is blocked 
in one direction due to prolonged refractory period in 
the injured tissue. The impulse therefore travels only 
clockwise around the ventricular wall. Traveling at 50 
em/sec such an impulse would close the loop around a 5 em 










Figure 1-l. Development of circus motions in rings of 
ventricular myocardium. (a) Normal excitation 
via subendocardial Purkinje fibers. (b) Ex-
citation during a typical PVC, originating at 
an irritable focus. (c) Excitation by a PVC 
originating at the edge of a transiently re-
fractory area, leading to a self-perpetuating 
circus motion. (d) Development of a circus 
motion in a dilated heart. 
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adequate time for the muscle first stimulated by the PVC 
to recover sufficiently to be excited by the "reentrant" 
impulse. Under these conditions, a self-propagated "circus 
motion" would develop, that is, the impulse would be con-
ducted around and around the myocardium. 
The time available for recovery of the initially 
excited myocardium and the probability of development of 
circus motions are enhanced in failing hearts which are 
both injured and dilated. In such hearts, the path length 
of potential circus motions is increased (Figure 1-l(d)). 
For example, in a dilated 8 em diameter ventricle (25 em in 
circumference) , a blocked unidirectional impulse would 
require 500 msec to travel completely around the wall, 
allowing ample time for recovery of initially refractory 
fibers. 
The Impulse Wavelength 
From Figure 1-1 it is evident that the impulse conduc-
tion velocity multiplied by the refractory period gives 
the length of the strip of refractory myocardium. The 
product of conduction velocity and effective refractory 
period may be defined as the "wavelength" of the impulse 
of depolarization. A normal value for the impulse wave-
length in mammals is about 10-30 em (Hoffman and 
Cranefield, 1960). As illustrated in Figure 1-l(d), if 
the impulse wavelength is less than the ventricular 
7 
circumference then the development of circus movements 
becomes possible, especially in the presence of patchy 
areas of refractoriness caused by ischemia, cooling, or 
rapid, repetitive stimulation. On the other hand, small 
hearts of circumference less than 10-30 em (diameter less 
than 3-10 em) may be unable to sustain fibrillation accord-
ing to the circus motion theory. Rabbits possess hearts 
with dimensions equal to or below the theoretical limit 
for circus motion, and indeed smaller rabbit hearts will 
not sustain fibrillation at normal body temperatures 
whereas larger rabbit hearts may fibrillate (Geddes, 1977). 
The Relation of Circus Motions to Fibrillation 
If a circus motion of the type diagrammed in Figure 
1-1 occurred circumferentially about the long axis of a 
left ventricle composed of uniformly excitable tissue, 
the rhythm known as ventricular flutter would be present. 
Ventricular flutter usually exists only for a short time 
and usually degenerates into fibrillation. Because of the 
asymmetrical geometry of the heart, the depolarization 
wavefront of a circus motion soon breaks up into multiple 
wavefronts upon encountering the junction between right 
ventricular free wall and interventricular septum, the 
mitral and tricuspid valve rings, or islands of refractory 
tissue. The closed-loop pathways permitting ventricular 
re-excitation become multiple, convuluted, and ever-
changing as true ventricular fibrillation develops. 
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The Ectopic Focus Theory 
The ectopic focus theory concerning the electrical 
events leading to fibrillation was proposed by Scherf and 
Terranova (1944). They postulated that rapid, repetitive 
excitations arise spontaneously from hyperirritable foci of 
myocardium to which the cardiac tissue is unable to respond 
in a synchronous fashion. Friedberg (1966) has suggested 
several mechanisms by which such ectopic foci could arise. 
First, several of the areas of latent pacemaker tissue 
might become active simultaneously, for example, in response 
to beta adrenergic hormones. Second, electrical potentials 
might be created between different areas of cells, resulting 
in stimulation of the fibers. Such potentials might 
develop if some cells were damaged, and maintained 
resting membrane potentials less than the potentials found 
in normal adjacent fibers. Finally, cells which do not 
normally act as pacemakers might become pacemakers under 
pathological circumstances. Heart size is also an important 
factor in the multiple pacemaker theory, in that the 
likelihood of multiple pacemaker sites increases when 
larger masses of tissue are available. Both the circus 
motion theory and the ectopic focus theory may be invoked 
to improve one's understanding of the phenomenon of 
ventricular fibrillation. The ectopic focus theory 
emphasizes pathophysiologic factors which can initiate 
ventricular fibrillation. The circus motion theory 
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emphasizes pathophysiologic factors w·hich lead to the 
perpetuation of ventricular fibrillation. A synthesis of 
both theories is therefore possible in which the presence 
of ectopic foci in sufficiently large hearts may lead to the 
phenomenon of sustained ventricular fibrillation. 
Hechanisns of Defibrillation 
Application of a strong, electric shock to the heart 
is the only dependable and definitive therapy for 
ventricular fibrillation. When properly applied, this 
shock causes all heart muscle fibers to cease contracting 
and stops the fibrillation. Usually, within a few seconds 
after the shock, a normal pacemaker will begin triggering 
synchronous ventricular contractions and cardiac pumping 
is resumed. 
The phenomenon of electrical ventricular defibrillation 
was first reported by Prevost and Battelli (1899 a-d). 
However, interest in the phenomenon was not revived until 
after Hooker (1930) had developed the chemical method of 
defibrillation. This method, which was used ~:;vhen appro-
priate in clinical medicine until the late 1950s, involved 
injecting KCl solution directly into the left ventricle. 
Massage of the heart, especially with occlusion of the 
thoracic aorta, forced the potassium solution into the 
coronary circulation. This achieved defibrillation but 
also left the heart completely hypodynamic. Therefore, 
CaC1
2 
solution was next injected into the left ventricle 
and massaged into the coronary bed to expel the KCl and 
counteract its depressant effect. Subsequently Hooker, 
Kouwenhoven, and Langworthy (1933) came upon the Prevost 
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and Battelli papers and confirmed that although low 
intensity alternating current shocks produced ventricular 
fibrillation, higher intensity shocks could arrest fibrilla-
tion. After over a decade, the technique of 60 Hz alterna-
ting current defibrillation was introduced into clinical 
medicine by Beck (1947), using electrodes applied directly 
to the heart,and Zoll (1956), using transchest electrodes. 
Thereafter several investigators including Gurvich (1947), 
Kouwenhoven (1954), and Lown (1962) discovered that, com-
pared to alternating current shocks, a brief direct current 
shock provided by discharge of a capacitor or a capacitor 
in series with an inductor could also defibrillate the atria 
with less danger of producing ventricular fibrillation at low 
shock intensity. These studies led to the development of 
modern defibrillators, most of which contain a capacitor 
and an inductor. The capacitor is charged by a direct current 
power supply to a preset voltage. At the time of de-
fibrillation, the capacitor is switched in series with the 
inductor and the subject. A heavily damped sinusoidal 
pulse of current lasting 2-10 msec is thereby delivered. 
If the current passes through a critical mass of myocardium 
and is of sufficient intensity, defibrillation is 
routinely achieved. 
The Electrophysiologic Requirement for Defibrillation 
ll 
The effect of current delivered by defibrillators 
upon the cellular electrophysiology of the heart has not 
yet been studied directly. This section presents a theory 
which indicates that although extremely high currents and 
voltages appear across the heart and thorax during de-
fibrillation, the stimulus at the cellular level is 
physiologic, and inherently nontoxic if properly applied. 
Moreover, the hypothesis supports the notion that the 
actions of drugs upon transmembrane ionic conductances and 
equilibrium potentials should influence the effectiveness 
of electrical ventricular defibrillation. 
The fundamental tenet of the hypothesis is that the 
essential requirement for defibrillation is excitation of 
a critical mass of the nonrefractory cells in the myo-
cardium (Zipes, 1975). It must be recognized that at any 
instant in time during fibrillation myocardial cells may 
be found in any phase of polarization (Figure l-2) . 
Phases 0, l, 2, 3, and 4 of the cardiac action 
potential, identified in the literature of cardiac electro-
physiology (Vassale, 1977; Arnsdorf, 1976, Hoffman and 
Cranefield, 1960), are defined as follows. Phase 4 is the 








-0. 5· +0,5 
TIME (sec) 
Figure 1- 2. Temporal dispersion of action potentials in 
fibrillating myocardium. Action potentials of 4 
hypothetical cells, A, B, C, and D are indicated as 
functions _ of time. During fibrillation cells may be 
found in any stages of_polarization at any instant 
in time. During fibrillation Phase 4 is usually 
abbreviated (Cells B and C), and often excitation 
may occur in the latter part of Phase 3 (Cell A) ; 
•the height_of _ty~ical action potentials in 
fibrillation is about 75 mV (Sano, 1958). 
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of the cell negative). During Phase 4 small inward sodium 
and outward potassium ionic currents are in balance for 
working myocardial cells. In pacemaker cells, gradual 
diastolic depolarization may occur due to an imbalance in 
these ionic currents. Phase 4 is succeeded by Phase 0, 
or depolarization, the rapid upstroke of the cardiac action 
potential. Phase 0 is associated with a rapid increase in 
sodium conductance and inward sodium current caused by 
suprathreshold stimulation of the cell, as the transmembrane 
potential is caused to exceed a critical ''firing threshold" 
voltage (typically -50 to -60 mV). Phase 1 is the brief 
overshoot or reversal of the transmembrane potential at 
the time of maximal sodium conductance. Phase 2, the 
plateau of the cardiac action potential, has recently been 
shown to be sustained by inward calcium current. In Phase 
3 potassium conductance becomes dominant and the resultant 
outward potassium current leads to repolarization of the 
cell and a return to Phase 4. During Phases 0, 1, and 2 the 
cell cannot be stimulated, since it is already depolarized. 
This period is defined as the absolute refractory period. 
During the midportion of Phase 3, the descending limb of 
the action potential, the cell may be stimulated by supra-
threshold stimuli and is said to be relatively refractory. 
During the terminal portion of Phase 3, the cell may be 
hyperirritable. 
14 
If fibrillation is conceived as the presence of 
numerous randomly oriented wavefronts of depolarization, 
spreading throughout the myocardium as represented in 
Figure 1-3, then electrical defibrillation requires 
simultaneous excitation of the cells just ahead of each 
wavefront. These cells would be found either in Phase 4 of 
polarization or in the latter part of Phase 3. A critical 
assumption of this hypothesis is that for the purpose of 
defibrillation the cells requiring the strongest stimulus 
for excitation are those completely repolarized cells in 
Phase 4. A noteworthy implication of this assumption is 
that it is not necessary to excite those cells in the 
midportion of Phase 3, which are relatively refractory, in 
order to defibrillate. Nor is it necessary to effect 
cells in Phases 0, 1, or 2. The hypothesis assumes that it 
is necessary only to depolarize one side of the cell membrane 
of each cardiac muscle cell to the extent of the difference 
between the resting (Phase 4) membrane potential and the 
cellular firing threshold. This stimulus would be 
sufficient to excite all fully recovered cells as well as 
all cells just emerging from their relative refractory 
period. 
The Action of Defibrillating Current 
At the Cellular Level 
Consider a rectangular block of ventricular myocardium 
containing muscle cells, extracellular fluid, blood vessels, 
• 




Figure 1-3. Schematic representation of multiple, random 
wavelets of depolarization traversing the ventricles 
during fibrillation. Heads of arrows indicate the 
wavefront of each wavelet and its direction of propaga-
tion. Tails of arrows indicate length of refractory 
tissue strips trailing each wavefront. ~~en a wave-
front encounters a refractory strip it will split 
into daughter wavelets or become extinguished. In 
sustained fibrillation successive generations of 
wavelets are always able to spread into areas of 
excitable myocardium. In theory, an effective 
stimulus from a defibrillator simultaneously excites 
and renders refractory the tissue just ahead of 
each wavefront, abolishing their propagation. 
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and connective tissue. Assume that the long axes of the 
muscle cells are oriented perpendicular to the flow of 
defibrillating current as would be true for most of the 
circumferential ventricular fibers in open chest defibrilla-
tion (Figure l-4(a)). Consider a very thin section of 
this block of tissue lSv thick and lcm2 in surface area, as 
illustrated in Figure l-4(b). The lSv thickness is chosen 
because this is the diameter of a typical ventricular muscle 
fiber. This thin slice of tissue can be divided conceptually 
into resistive and capacitive components, as shown in Figure 
l-4(c). The resistive component consists of the electrolyte 
filled extracellular space which comprises about 30 percent 
of the volume of mammalian ventricular muscle (Frank and 
Langer, 1974). The capacitive component consists of muscle 
and connective tissue cells, about 70 percent of ventricular 
volume, which are surrounded by high resistivity cell 
membranes. The cell membranes of cardiac muscle have been 
modeled as parallel resistive-capacitive networks (Woodbury, 
1962) , but me~~rane resistance is so large with respect to 
the extracellular fluid resistance (2,000 ohms for lcm2 
versus 0.3 ohms for lcm2 ) that menilirane resistance can be 
ignored for the present discussion and the membranes con-
sidered as purely capacitive, as shown in Figure l-4(d). 
If a direct current pulse is applied to the network 
depicted in Figure l-4(d), current will flow initially 
onto the series capacitors, causing them to charge. This 
1 em -----+ · · 
( a ) (b) 
(c) 
Figure 1-4. Scheme for analysis of the action of de-
fibrillating current upon myocardial cells. (a) 
Bundle of myocardial fibers oriented perpendicular 
to electric current field. (b and c) Hypothetical 
tissue element 1 cm2 in cross-sectional area and 
one cell diameter in thickness, containing cells 
and extracellular fluid. (d) Equivalent circuit 
for hypothetical tissue element. 
17 
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charging of membrane capacitance will tend to depolarize 
the ca tho::lal side and hyperpolarize the anodal side of 
the cell. The time for membrane capacitors to charge 
maximally is about five''RC"time constants; thereafter all 
of the current flows through the extracellular fluid 
resistance, at which time the final voltage across both 
series capacitors is equal to the voltage drop across the 
resistor, RE,...,.. . ....... 
Values of R and C from the literature may be sub-
stituted into the equivalent circuit of Figure l-4(d) in 
order to estimate the gross electrical effects of the 
passage of a 100 majcm
2 
threshold pulse of defibrillating 
current through the hypothetical 15~ x 1 cm2 slice of 
myocardium. The estimate of 100 ma/cm
2 
threshold current 
density is derived from data on open-chest defibrillation 
with electrodes of specified size,obtained recently in 
our laboratories (Grubbs and Wilcox, 1975) . This figure is 
also consistent with estimates derived from published open-
chest threshold data (Geddes, 1970; 1974). Membrane 
capacitance of Purkinje fibers has been measured by Weidmann, 
(1952) and confirmed by others (Arnsdorf and Bigger, 1975), 
who obtained a value of approximately lO~F for lcm2 of 
membrane. These authors also determined the overall 
resistivity of intracellular fluid to be approximately 100 
ohm-em. The resistivity of extracellular fluid is assumed to 
be approximately that of plasma, or about 60 ohm-em. Given 
19 
these values, the resistances and capacitances of Figure 
l-4(d) may be calculated and are indicated in Figure 1-5. 
The resistance of the extracellular fluid, indicated in 
Figure 4-l(c), is the product of the resistivity of the 
medium and the "length" of the fluid slab in the direction 
parallel to current flow, divided by the cross-sectional 
area of the fluid slab: 60 ohm-em x 0.0015 cm/0.3 cm2 or 
0.3 ohm. The final voltage to which both series membrane 
capacitors are charged by a 100 ma/cm2 defibrillating shock 
is 100 rna x 0.3 ohm or 30 mV. 
Charging the membrane capacitors results in hyper-
polarization of the anodal side and depolarization of the 
cathodal side of the typical 15~ diameter cell, shown in 
Figure l-5(b). If 30 mV potential difference is divided 
equally across the series membrane capacitors, the anodal 
side of the 15 micron cell is depolarized by 15 mV and the 
cathodal side hyperpolarized 15 mV. Such a change is of the 
order of that necessary to bring the transmembrane potential 
on the cathodal side of the cell from a resting potential to 
the firing threshold. 
Note that if the myocardial fibers in the hypothetical 
block of tissue were oriented parallel rather than per-
pendicular to the direction of current f lov1, the 11 length 11 
of the slab of extrafluid extracellular fluid would be 
greater. A greater final voltage difference would develop 
across this distance causing correspondingly greater changes 
20 
i I = 100 ma 
i 
0.3Q 30 mV 
-15~ __ _, 1 
(a) 
(b) 
Figure 1-5. Equivalent circuit for a hypothetical slice 
of myocardium 1 cm2 in cross-sectional area and one 
cell diameter in thickness. (a) Approximate values 
of the circuit elements. (b) Steady state voltage 
differences caused by the passage of an electric 
current of defibrillating intensity. 
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in the transmembrane potential at the cathodal and anodal 
ends of the cell. Hence any shock able to stimulate 
fibers oriented perpendicular to the current flow would 
also be able to stimulate fibers oriented parallel to the 
current flow. 
Also note that the time for membrane capacitance to 
charge to very near the maximal voltage is a matter of 
several "RC" time constants for the myocardial cells. Using 
the values 10 ohm-cm
2 
for membrane capacitance, 100 ohm-em 
for intracellular fluid resistivity, and 0.0015 em for cell 
2 length and 1 em for aggregate cell surface area, the time 
-6 
constant for charging of membrane capacitance is 5 x 10 
sec. The time constant for voltage-dependent activation of 
sodium conductance, however, is much longer, on the order 
of 0.5 msec (Ehrenstein, 1976; Hodgkin and Huxley, 1952). 
The passage of current through cardiac tissue via macro-
electrodes rapidly changes the transmembrane potential of 
cells within a few microseconds. However, the cathodal 
side of the cell must remain above the firing potential 
for several milliseconds before sodium activation will 
become sufficient to cause rapid sodium inrush, depolarization, 
and refractoriness. 
The hypothesis presented in this thesis is that the 
essential requirement for defibrillation is depolarization 
of one side of cardiac cells by a voltage equal to the "gap" 
Er - Eth' between the resting membrane potential and the 
22 
cellular firing threshold for a sufficient time to allow 
activation of sodium conductance. Since the amount of de-
polarization is proportional to the current density 
delivered by the shock, drugs could conceivably alter the 
current required for defibrillation by altering either the 
firing threshold, Eth' or the resting membrane potential, 
E . 
r 
Possible Mechanisms of Drug Action 
Agents which raise the cellular firing threshold, 
hyperpolarize resting cells, or both are predicted to 
increase the Er-Eth gap and the current required electrical 
stimulation or defibrillation of the heart. Agents which 
decrease the cellular firing threshold, hypopolarize resting 
cells, or both are predicted to decrease the gap and the 
current required for stimulation or defibrillation of the 
heart. 
The likely ways in which drugs might produce such 
changes may be appreciated with reference to established 
principles of cardiac membrane physiology for cells in 
Phase 4 and Phase 0. 
The transmembrane potential, E , is the voltage to m 
which the cell membrane capacitance is charged at any 
instant in time. E is determined by the balance of ionic m 
currents across the membrane. Although the importance of 
calcium currents in maintaining E have been recently m 
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identified for ventricular muscle cells during Phase 2 
(Beeler and Reuter, 1970; Gibbons and Fozzard, 1975), the 
ions involved in Phase 4 and Phase 0 are almost exclusively 
sodium and potassium for both ventricular muscle and for 
nerve (Hoffman and Cranefield, 1960; Vassale, 1977). The 
net ionic current from one side of the cell membrane to 
the other depends upon the membrane conductance (g) of the 
ion and the electrical driving force impelling the ion. The 
driving force is defined as the difference between the 
equilibrium potential for the ion (E. ) and the instantaneous 10n 
membrane potential (Em). The resultant net ionic current 
may be predicted by the ohmic relationship 
I . = g. (E - E . ) • 
1on 1on m 10n 
The equilibrium or reversal potential, E. , is determined 10n 
by the ratio of intracellular to extracellular concentration 
of the ion by the Nernst equation 
E. 1on 
[ion] . = RT n l 
F x,n[ion] 
0 
where square brackets indicate molar concentrations, and the 
subscripts i and 
0 
denote "inside and "outside" the cell. 
Evaluating the physical constants and converting to common 
logarithms, the Nernst equation becomes E. (in mV) = 10n 
61.5 log{[ion]i/[ion] 0 }, for monovalent cations at body temp-
erature selectively permeable to the membrane. The ionic 
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conductance, g(ion), is a function of both E and of time. m 
The time dependence of g(ion) reflects the kinetics by 
which presumed ionic channels traversing the membrane open 
and close following a change in E . 
m 
During Phase 4 and Phase 0, the membrane potential is 
determined by the balance between the transmembrane sodium 
current, INa' and the transmembrane potassium current, IK. 
Since EN is positive (typically +80 mV) and greater than 
J: a 
Em,and since EK is negative(typically -90 mv);the sodium 
current is inward, tending to depolarize the cell, and the 
potassium current is outward, tending to hyperpolarize the 
cell. The gNa at the time of the transition between Phase 
4 and Phase 0 is a rapidly increasing (concave upward) 
function of Em; whereas gK is assumed to be approximately 
constant. More rigorous theoretical expressions for gNa 
and gK of nerve-cell membranes as functions of voltage 
and time have been described elsewhere (Ehrenstein, 1976; 
Hodgkin and Huxley, 1952), which indicate that there is a 
measurable voltage dependent increase in gK during Phase 0. 
However, compared to the very large increase in gNa during 
excitation, gK remains relatively stable just before and 
after the onset of Phase 0. Only later, after Phase 0 
has irrevocably begun, does potassium conductance markedly 
increase (Hodgkin and Huxley, 1952). The present discussion 
is concerned only with events just before and after the 
rapid sodium influx which initiates Phase 0, so it is 
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reasonable as a first approximation to treat gK as a constant.* 
Given the assumptions that gNa is an accelerated 
function of E and that gK is essentially constant at the m 
time of excitation, the transmembrane currents involved may 
be illustrated as shown in Figure l-6(a). This figure illus-
trates hypothetical transmembrane sodium and potassium 
currents, as conceived by the author, at different levels 
of Em. IK is a linear function of Em' increasing as the 
membrane potential is made more positive than the potassium 
equilibrium potential. INa is an accelerated function of 
Em' indicating the voltage dependent increase in gNa as 
the membrane potential is made less negative. To permit 
easy comparison of the magnitudes of the ionic currents in 
opposite directions across the membrane, the absolute values 
of INa and IK are plotted. The straight line for potassium 
current and the curved line for sodium current intersect 
at two points for which INa = IK. The left-hand point is 
a stable equilibrium and indicates the resting membrane 
potential. The right-hand point is an unstable equilibrium 
and indicates the cellular firing threshold. This feature 
of Figure l-6(a) may be appreciated by considering the 
effects of hyperpolarizing and depolarizing electrical 
* If gK is considered more exactly as an increasing function 
of Em with a derivative significantly less than that of the 
gNa versus Em curve, the predictions of the present theory 
would be qualitatively the same with only minor quantita-
tive differences. 
( a ) 
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Figure 1-6. Balance of inward sodium and outward potassium 
currents in ventricular myocardial cells during Phase 
4 and early Phase 0. (a) Absolute values of sodium 
and potassium currents are plotted as a function of 
transmembrane potential, Em· Zones 1, 2, and 3 of 
the Em domain are identified. (b) Effects of altera-
tion of Em by electrical stimuli. If Em is tran-
siently driven into Zone 1 or Zone 2 it will return 
to the stable equilibrium value, Er. If Em is driven 
into Zone 3, an action potential will be initiated. 
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stimuli which might be delivered via an intracellular 
microelectrode connected to a constant current source. The 
results of such hypothetical stimulation are shown in 
Figure l-6(b). Suppose a hyperpolarizing current is used 
to drive the E more negative than E into the zone denoted m r 
(1). After the current is terminated, the inward sodium 
current will be greater than the outward potassium current, 
and the cell will depolarize until INa = IK at the resting 
membrane potential. If a low amplitude, depolarizing 
current is delivered, driving the E into zone (2) and m 
then terminated, the outward potassium current will be 
greater than the inward sodium current, again driving the 
Em back toward the Er. Such a current would constitute a 
subthreshold stimulus. However, if a stronger depolarizing 
current were to drive the E into zone (3) , the inward m 
sodium current would exceed the outward potassium current, 
causing further depolarization of the cell and initiating 
Phase 0. Such a current would constitute a suprathreshold 
stimulus. The right-hand intersection of the sodium and 
potassium current functions, therefore, represents the 
cellular firing threshold. The voltage gap Er - Eth to 
which the membrane capacitance of the cell must be charged 
to initiate an action potential is represented by the 
horizontal distance between the intersections of the sodium 
and potassium current functions. 
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Prediction of Drug Effects 
Using this graphical representation of the critical 
ionic currents involved in excitation of the cell, it is 
easy to identify four general mechanisms by which drugs 
could alter the strength of the electrical stimulus required 
to excite the cell. These include alteration of the gK, 
alteration of the gNa, alteration of the EK, and alteration 
of the ENa· 
For example, if a drug increased gK by a factor a > 1, 
the slope of the IK line in Figure l-6(a) would be increased. 
As a result, Er would become slightly more negative, Eth more 
positive, and the voltage gap, Er- Eth' would increase;so 
that a stronger stimulus would be required to excite the 
cell. Similarly, if gNa were decreased by a factor a < 1, 
the gap between Er and Eth would also increase. If potassium 
conductance were increased and sodium conductance decreased 
simultaneously, then an even greater increase in the stimula~ 
tion threshold would occur. Conversely, if gK were de-
creased, gNa were increased, or both, the Er - Eth gap would 
decrease together with the stimulation threshold. These 
possibilities are summarized in Table 1-1. 
In addition to altering the relationship between sodium 
and potassium conductance of the membrane, drugs might also 
influence the stimulation threshold by directly or in-
directly altering the sodium or potassium equilibrium 
potentials. Since the difference E - EN is large (about m a 
Table 1-1 Predicted effects on cardiac stimulation or 
defibrillation threshold caused by changes in 
transmembrane ionic conductances during 
diastole. 
gNa 

















l = increased threshold l = decreased threshold 
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-160 mV) relatively large changes in ENa would be re-
quired to cause large percentage changes in I = gNa(E -Na m 
ENa). However, in the case of potassium, Em - EK is 
relatively small (about 10 mV) . Hence smaller changes in 
the EK caused by disturbances in the ratio of local extra-
cellular to intracellular potassium concentration could more 
easily produce large percentage changes in the stimulation 
threshold. Such changes would be represented graphically 
in Figure l-6(a) as a parallel shift in the potassium current 
line. For example, increased extracellular K would cause 
the potassium current line to shift to the right, narrowing 
the Er - Eth gap and reducing the stimulation threshold. 
Summary of the Theory 
The theory of defibrillation developed in this chapter 
assumes that fully recovered and almost fully recovered 
cells in the fibrillating heart must be brought to the 
cellular firing threshold, excited, and hence rendered 
refractory to achieve defibrillation. The critical variable 
in determining the strength of the stimulus required is 
the voltage difference or "gap" between the firing 
threshold and the minimal (resting) membrane potential of 
completely recovered cells. The magnitude of this voltage 
gap is determined by the balance of inward sodium current 
and outward potassium current across the cell membrane. 
According to accepted principles of membrane physiology, 
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the factors which affect this balance include the 
potassium conductance of the membrane, the sodium conductance 
of the membrane, and the equilibrium potentials for sodium 
and especially for potassium. Since all of these factors 
may be altered by selected drug actions, it is highly likely 
that drugs may alter the threshold for electrical ventricular 
defibrillation. 
Rationale 
To demonstrate drug-induced alterations of the 
ventricular defibrillation threshold experimentally, it is 
necessary to choose a species of animal with hearts large 
enough to sustain fibrillation. The hearts of small, 
inexpensive laboratory animals, such as rats, will not 
sustain fibrillation, probably because the impulse wave-
length in mammalian myocardium exceeds the length of 
conduction pathways in such small hearts. 
In the studies to be described, the dog was selected as 
the experimental animal. These studies were carried out in 
intact animals using transchest defibrillating electrodes 
in order to ensure that any pharmacological effects ob-
served were physiologically important. Three drugs were 
selected for initial study: quinidine, lidocaine, and 
potassium chloride. These agents are well known. They 
produce selective effects upon cardiac electrophysiology 
in the intact animal at dose levels which do not produce 
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profound systemic toxicity involving other organ systems, 
and are thus appropriate for transchest defibrillation 
studies. Each produces reasonably well-characterized 
alterations in either sodium conductance, potassium 
conductance, or potassium equilibrium potential, and hence 
is likely on a theoretical basis to influence the de-
fibrillation threshold. 
Alteration of Myocardial gNa and gK by Quinidine and 
Lidocaine 
The literature concerning the mechanisms of action 
of antiarrhythmic drugs has been recently reviewed 
(Singh, 1977; Arnsdorf, 1976; Hauswirth, 1974; Bassett and 
Wit, 1973; Rosen and Hoffman, 1973). This literature is 
complicated by the study of drug action using diverse tissue 
preparations, including atrial muscle, Purkinje fiber bun-
dles, ventricular muscle, motor nerve, and squid axon; 
diverse species including frog, rat, guinea pig, dog, and 
human; and diverse extracellular potassium concentrations. 
Direct investigation of the ionic mechanisms of antiarrhyth-
mic drug action in cardiac muscle using preparations analo-
gous to the voltage-clamped squid axon has been technically 
difficult due to the small size and contractility of 
cardiac muscle cells. Recent applications of voltage-
clamp techniques to cardiac muscle (Beeler and Reuter, 1970; 
Fozzard and Beeler, 1975) have produced promising results. 
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However, this approach remains limited in cardiac muscle, 
especially by capacitance-induced artifacts during the up-
stroke (Phase 0) of the action potential. As a result, 
conclusions about the ionic mechanisms of antiarrhythmic 
drug action on excitation of cardiac muscle fibers must be 
drawn from indirect evidence. 
Quinidine. 
Most authorities believe that quinidine acts primarily 
by decreasing transmembrane sodium conductance. Virtually 
all investigators since Weidmann (1955) have found that 
quinidine decreases the rate of rise of Phase 0 of the action 
potential (dV/dt)
0 
recorded with intracellular electrodes. 
This effect is associated with a decreased slope and increased 
duration of the QRS complex of the electrocardiogram, which 
is readily demonstrated in the experimental animal and in 
human patients (Gettes, 1962; Prinzmetal, 1970; Heissenbuttel 
and Bigger, 1970). Such a correlation of changes in (dV/dt) 0 
and the QRS complex are predicted by the interference theory 
of electrocardiography (Geddes and Baker, 1975)*. These 
quinidine-induced changes are antagonized by hyperpolarization 
(Weidmann,l955;Hoffman and Cranefield,l960)which would in-
crease inward sodium current in the presence of depressed 
gNa, as predicted by the expression IN = gNa(E - EN ) . a m a 
* The interference theory states that the electrocardiogram 
(ECG) is derived from the instantaneous difference between 
the excursion in transmembrane potential of two adjacent 
areas of myocardium which are activated sequentially by the 
same wavefront of depolarization. For example, in mammals 
the subendocardial tissue of the ventricles is first 
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Quinidine elevates the cellular firing threshold as measured 
with intracellular electrodes (Weidmann, 1955; Yeh, 1976). 
The major effect of quinidine is thus usually attributed to 
decreased sodium conductance of the membrane. At higher 
concentrations of quinidine, secondary effects attributable 
to decreased potassium conductance occur. These include 
prolongation of the action potential duration, refractory 
period, and QT interval of the electrocardiogram (Rosen 
and Hoffman, 1970; Heissenbuttel and Bigger, 1970). 
Depression of both sodium and potassium conductance by 
quinidine to a roughly equal degree has been demonstrated 
by direct measurements of ionic currents in voltage-clamped 
squid axons (Yeh, 1976). However, McCall (1976), using 42K 
and 24Na radioisotope tracer techniques in cultured human 
heart cells, found that the percent decrease in the 
calculated sodium permeability coefficient (pNa) of the cell 
activated by Purkinje fibers. A wavefront of depolarization 
then spreads to the subepicardial fibers which are activated 
a time, 6t, later; where 6t is the propagation time required 
for depolarization to spread from the subendocardial to the 
subepicardial fibers. The time 6t is related to the propaga-
tion velocity, c, of the wavefront of depolarization and the 
distance, 6x, between the sequentially activated areas of 
myocardium by the expression 6t=6x/c. According to the 
interference theory, the ECG amplitude is proportional to 
the instantaneous difference in transmembrane potential, 6V, 
between these two areas of tissue. It follows that 
6x 
c 
Noting that the propagation time, 6t, is small compared to 





membranes was approximately twice the percent decrease in 
calculated potassium permeability coefficients of the cell 
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membranes after exposure to 10 to 10 ·molar quinidine. 
Assuming that quinidine acts by decreasing trans-
membrane sodium conductance greater than potassium conduc-
tance, one may predict its effect on defibrillation threshold. 
On the basis of the theoretical analysis summarized in 
Figure l-6(a) one would expect quinidine to shift the sodium 
current curve downward and to the right. Such a shift 
would slightly lower the resting membrane potential and 
raise the cellular firing threshold. The resultant increased 
"gap" between these two equilibrium voltages would, in 
theory, cause an increase in the stimulation or defibrillation 
threshold. The same net effect on the gap voltage would be 
expected if the sodium conductance were decreased by a factor 
greater than that for potassium conductance. 
Thus the electrocardiographic signal is directly proportional 
to the derivative of the cellular transmembrane potential 
and the distance between the sequentially activated areas 
of myocardium (in this case ventricular wall thickness) and 
inversely proportional to propagation velocity. For 
example, in left ventricular hypertrophy, the amplitude of 
the QRS complex is greater than normal due to increased 
ventricular wall thickness, 6x, in accordance with equation 
(1). The amplitude of premature ventricular contractions 
in the ECG may be greater than normally conducted beats 
because the distance between sequentially activated areas 
of muscle, 6x, is larger and because the effective propaga-
tion velocity, c, is smaller due to bypass of Purkinje 
fibers penetrating the ventricular wall. 
Assuming that the major electrophysiologic effect of 
quinidine at the cellular level is to decrease (dV/dt) 0 and prolong Phase 0, without altering the final amplitude of 
the action potential, the interference theory predicts two 
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Lidocaine. 
Lidocaine appears to act by increasing transmembrane 
potassium conductance, probably to a greater degree in 
Purkinje fibers than in working myocardial cells (Davis and 
Temte, 1969; Arnsdorf and Bigger, 1972). In therapeutic 
concentrations, lidocaine, unlike quinidine, has little 
effect on (dV/dt)
0 
(Davis and Temte, 1969; Bigger and 
Mandel, 1970), indicating that blockade of sodium conductance 
is not the most important mechanism of lidocaine action. 
Positive physiological correlates of lidocaine action 
include decreased rate of Phase 4 diastolic depolarization 
of pacemaker cells (Davis and Temte, 1969; Bigger and Mandel, 
1970), which has been attributed to a progressively de-
creasing potassium conductance (Trautwein, 1973). Increased 
potassium conductance during Phase 4 in response to lidocaine 
changes in the QRS complex of the electrocardiogram. The 
first is a decrease in the amplitude of the QRS complex 
due to decreased dV/dt. The second is an increase in 
the duration of the QRS complex, since dV/dt will remain 
positive for the longer time required for complete de-
polarization. (Both of these effects occurred in 
the quinidine studies reported in Chapter 3) . The 
first effect may be antagonized by the concomitant 
decrease in conduction velocity produced by quinidine, 
since propagation velocity appears in the denominator 
of equation (1). Hence the second effect, prolongation 
of the QRS complex, is a more reliable sign of quinidine 
effect in the electrocardiogram. 
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would thus explain this aspect of its antiarrhythmic 
action. Lidocaine also may decrease the action potential 
duration and refractory period of cardiac cells, a phenomenon 
consistent with increased potassium conductance during 
Phase 3 repolarization (Mandel and Bigger, 1971). In 
Purkinje fibers depolarized by injury, exposure to lido-
caine may cause a return of the resting membrane potential 
toward normal (Arnsdorf and Bigger, 1972). This phenomenon 
is consistent with the expectation that increased potassium 
conductance, gK, would cause a greater stabilizing current, 
IK = gK(Em - EK), when Em is farther from the EK in de-
polarized cells. Recently Arnsdorf and Bigger (1975), using 
multiple microelectrodes and cable theory applied to long 
cardiac Purkinje fibers, have measured a 64 percent increase 
in membrane potassium conductance after exposure to 
therapeutic concentrations (5 mg/1) of lidocaine. Kabela has 
t d . d 42 ffl f d h . f repor e 1ncrease K e ux rom og eart t1ssues a ter 
exposure to lidocaine. This body of evidence strongly 
suggests increased potassium conductance as the therapeutic 
mechanism of lidocaine action upon the heart. 
At higher concentrations, or in the presence of higher 
extracellular potassium levels (Singh and Vaughan Williams, 
1971), lidocaine begins to exert "quinidine-like" effects. 
These include decreased amplitude, decreased rate of rise 
and prolonged duration of the action potential (Mandel and 
Bigger, 1971), and are attributable to decreased sodium 
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conductance. This quinidine-like action at higher con-
centrations has been proposed as the principle local 
anesthetic mechanism of procaine and lidocaine in peripheral 
nerves (deJong, 1970). 
The analysis of Figure l-6(a) predicts that lidocaine 
would increase stimulation and defibrillation threshold 
by raising the potassium current line and, at higher 
doses, lowering the sodium current curve. These shifts 
would widen the voltage gap between the equilibrium points 
for the resting membrane potential and the cellular firing 
potential,and~proportionally increase the current required 
for stimulation or defibrillation. 
Alteration of EK by Potassium 
The dependence of the potassium equilibrium potential, 
EK' and resting membrane potential, Em' upon the ratio of 
intracellular to extracellular potassium concentration 
(K./K )*has been well described by Hoffman and Cranefield 
~ 0 
(1960) and recently reinvestigated in terms of ionic 
activities by Miura (1977). These reports clearly indicate 
that the equilibrium potential for potassium is very 
sensitive to changes in K . This result may be appreciated 
0 
by differentiating the Nernst equation 
* In this and the following discussions, square brackets 
denoting molar concentrations of ions are omitted for 
simplicity of notation. 
K. 
EK = -61.5 log 1 
K 
0 

















Hence the transmembrane potential is normally 20-40 times 
more sensitive to changes in K than to changes in K .. 
0 l 
Small changes in extracellular potassium concentration may 
cause large changes in the potassium equilibrium potential 
and in turn the threshold current for defibrillation. 
Mathematical Feasibility of Varyihg K0 and Calculated EK 
While Keeping Ki Essentially Constant. 
Because measurement of intracellular potassium 
concentrations in the myocardium requires sacrifice of the 
experimental animal, it is desirable to keep K. levels 
l 
essentially constant during the course of an experiment. 
Then a single determination of myocardial K. at the end of 
l 
the experiment may be interpreted with some validity. As 
illustrated in Figure 1-7, the overwhelming majority of 
total body potassium (about 50 mEq/kg body weight) is found 
1/3 dry 
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Figure 1-7. Approximate normal distribution of potassium 
ions in body fluid compartments. TBW = total body 
water, ECF = extracellular fluid, ICF = intra-
cellular fluid. Roughly 98 percent of total body 
potassium is contained within cells. 
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intracellularly, whereas only about 1 mEq/kg is found in 
the extracellular fluid. If 1.0 mEq/kg of potassium is 
infused intravenously over 3-5 minutes, K will increase 
0 
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roughly 4 mEq/1 -- enough to double normal plasma levels. 
In practice, the intravenous dose of 1.0 mEq/kg produces 
about a 3.5 mEq/1 rise in plasma potassium levels in our 
laboratory. However, even if this entire potassium dose 
enters the cells, K. will be changed by only 2 percent. 
l 
Thus it is possible to significantly raise K by potassium 
0 
infusion while keeping K. essentially constant. 
l 
A "bolus plus infusion'' dosage schedule permits re-
peated determination of the defibrillation threshold at a 
specified K level. The mathematical rationale for the use 
0 
of a combined bolus plus infusion dosage schedule to 
produce a ''square" step-up in the plasma levels of a drug 
was described by Wagner (1974). Using this technique in 
dogs with bilateral ureteral ligation to prevent renal 
excretion, the maintenance of a stable elevation in K for 
0 
100 minutes requires the administration of 2.0 mEq/kg KCl. 
This total dose represents a 4 percent increase in total 
body potassium. Since plasma levels remain constant from 
the beginning to the end of the 100 minute period, about 
half the total dose of 2 mEq/kg must be transported into 
cells during 100 minutes of infusion. As a consequence, 
overall intracellular potassium levels increase by 
approximately 1 mEq/kg, or only about 2 percent at the end 
of 100 minutes. 
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Measurement of Intracellular Potassium Concentration. 
Because it is physically impossible to separate the 
intracellular and extracellular fluid compartments of solid 
tissues, intracellular potassium concentration must be 
calculated indirectly. The calculation can be made from 
measurements of total tissue and extracellular potassium 
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provided 0 , the volume fraction of the extracellular space 
0 
is known. Classically 0 is measured as the volumeo:f distribu-o 
tion of an indicator substance which is permeable to 
capillaries but which is excluded from cells. 24Na, 
thiosulfate, and manitol have been used as indicators for 
this purpose (Welt, 1970). The method developed by the 
author for the present studies employs nonisotopic sodium 
as the indicator substance. The sodium indicator is 
subtracted rather than added to the extracellular space as 
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the myocardium is perfused with two different isotonic 
solutions, the first (lactated Ringer's solution) containing 
physiologic sodium concentration and the second (5 percent 
dextrose in water) containing zero sodium concentration. 
Tissue samples are analyzed for total sodium and potassium 
content by flame photometry after each perfusion. Calcula-
tions are made as described in Chapter 3. 
In this manner it is feasible to study defibrillation 
threshold as a function of EK, by using a regulated KCl 
infusion to alter the K /K. ratio. K may be determined 
0 l 0 
from samples of blood plasma, and K. may be measured 
l 
terminally in the same animal with confidence that it has 
remained essentially constant during the experiment. 
With knowledge of both K
0 
and Ki, EK may be calculated from 
the Nernst equation and related to defibrillation threshold. 
Importance of the Stability of the Animal Model 
Before undertaking the drug studies, however, certain 
critical questions concerning the validity and the stability 
of the animal model must be addressed. These questions 
concern the effect of anesthesia and the reproducibility 
of control data obtained when no drug other than the 
anesthetic is administered. Attention to these questions, 
as described in Chapter 2, ensured that presumed effects of 
cardiac drugs on the defibrillation threshold would be 
correctly interpreted. 
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Objectives of the Investigation 
According to the preceding rationale, the objectives 
of the investigation described in this thesis were as 
follows: 
e To determine the effects of the induction of pento-
barbital anesthesia on ventricular defibrillation 
threshold. 
e To determine the stability and precision of control 
defibrillation threshold data in pentobarbital 
anesthetized dogs. 
e To determine the Affect of intravenous quinidine 
gluconate on ventricular defibrillation threshold. 
e To determine the effect of intravenous lidocaine on 
ventricular defibrillation threshold. 
e To determine the effect of elevated extracellular 
potassium concentration and potassium equilibrium 
potential on ventricular defibrillation threshold. 
e To compare observed drug effects with theoretical 
predictions. 
CHAPTER 2 
EVALUATION OF THE ANIMAL MODEL FOR 
PHA~ACOLOGIC STUDIES 
Pentobarbital Anesthesia 
All controlled experimental studies of electrical 
ventricular defibrillation reported to date have used 
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anesthetized animals as subjects in most cases barbiturate 
anesthetized dogs. In contrast, virtually all clinical 
ventricular defibrillation outside the operating room is 
carried out in unanesthetized patients in settings such as 
the coronary care unit or emergency room. Recently the 
barbiturate anesthetized dog has been criticized as a model 
of normal cardiovascular physiology(Priano,l969). Since no study 
can be found in the literature reporting the influence of 
anesthesia on the efficacy of electrical defibrillation, 
a reasonable question may be raised about the validity of 
anesthetized animal models used for defibrillation studies. 
Unquestionably, anesthetic agents of all kinds have 
direct effects upon excitable biologic membranes. Although 
the central nervous system is the most important site of 
action of general anesthetic agentsi many anesthetics, 
including pentobarbital, are known to affect the mechanical 
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and electrical performance of cardiac muscle. The amplitude 
and strength of myocardial contraction are depressed by 
cyclopropane, diethyl ether, nitrous oxide, and halothane, 
as well as by barbiturates including pentobarbital, seco-
barbital, and thiopental (Price, 1955; Flacke, 1962; 
Hardman, 1959; Effendi, 1973; and Etsten, 1955). Hydro-
carbon anesthetics may depress the rate of the sinus node 
pacemaker as well as the speed of atrioventricular and intra-
ventricular conduction (Flacke, 1962; Hardman, 1959; Effendi, 
1973; Etsten, 1955; Smith, 1962). Significant differences in 
the response of the dog heart to the atrioventricular block-
ing and arrhythmogenic actions of digitalis glycosides have 
been reported for animals anesthetized with pentobarbital 
versus halothane, versus methoxyflurane (Morrow, 1972). 
Cyclopropane, halothane, and to a lesser extent, thiopental, 
are known to sensitize the myocardium to the arrhythmogenic 
effects of epinephrine (Dressel, 1964). Thus, it is quite 
conceivable that anesthetics could alter those parameters of 
cardiac electrophysiology which determine the success or 
failure of electrical defibrillation. 
Accordingly, the following study was undertaken to deter-
mine if the induction of anesthesia with intravenous pento-
barbital sodium in the dog alters transchest defibrillation 
threshold. In this study, threshold was determined in the 
same animals in both the awake, unanesthetized state and 




Five dogs of mixed breed, weighing 6 to 14 kg 
served as subjects. Initially each dog was anesthetized 
with injectable pentobarbital sodium (NembutalR, 50 mg/ml 
10% alcohol, 40% propylene glycol vehicle, 25-30 mg/kg i.v.). 
No preanesthetic medication was given. A bipolar catheter 
electrode was placed in the right ventricle of the heart 
via a right jugular venous cut-down, using sterile technique. 
Position of the catheter electrode within the heart was 
verified by recording the catheter tip electrogram and 
comparing its timing with the electrocardiogram (ECG) Lead 
II. The catheter was stabilized in the jugular vein and 
the wound closed with 2-0 silk sutures. The external 
portion of the catheter was protected with an adhesive elastic 
bandage placed around the neck and a soft collar 8 em in 
width. After a recovery period of 36-72 hours, the de-
fibrillation threshold was determined before and after 
induction of anesthesia with pentobarbital. These investiga-
tions in unanesthetized and anesthetized subjects were 
carried out in accordance with National Institutes of Health 
and institutional guidelines for the use of laboratory 
animals (''Guide", 1972; "Regulations", 1972). 
Defibrillation threshold in awake, unrestrained animals 
was measured as follows: ECG Lead II electrodes were applied 
to the limbs and the position of the catheter electrode was 
confirmed by recording the catheter tip electrogram. 
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Defibrillating electrodes, held in position with rubber 
straps, were applied to the shaved skin of the thorax with 
electrolytic jelly, one centered over the apex beat area 
and the other in the opposite position on the right chest 
wall. The defibrillating electrodes were stainless steel 
discs, 2 mm thick and 8-10 em in diameter (20 percent of the 
animal's chest circumference + lcm). The standard location 
of each electrode was outlined in ink on the thorax. 
Ventricular fibrillation was produced by the applica-
tion of a 1 sec train of 60 Hz, 2 msec duration rectangular 
electrical pulses of 5-15 volts intensity via the right 
ventricular catheter. Ventricular fibrillation was con-
firmed by the presence of random waves in the electro-
cardiogram and by the descending level of consciousness of 
the subject. As the animal lost consciousness, it was 
placed in dorsal recombency. 
The defibrillator employed contained a 16 ~F capa-
citance,a 44 millihenry inductance, and a 7 ohm internal 
resistance in series with the subject. A 1.00 ohm, 100 watt 
resistor in series with one electrode was used for measuring 
current output. The peak output voltage of the defibrilla-
tor could be varied continuously from 0 to 8000 volts. 
The duration of the delivered current pulse, slightly 
dependent upon subject resistance, was typically 4-5 msec. 
The waveform of the current pulse was a heavily damped 
sinusoid. 
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As soon as possible after the confirmation of ventri-
cular fibrillation (15-45 sec after endocardial stimula-
tion), a defibrillator shock, calculated to be adequate 
for defibrillation on the basis of the dog's body weight 
as described by Geddes (1974), was delivered at the time of 
end-expiration. The voltage and current applied to the 
subject were measured using a Tektronics model D-11 dual 
channel storage oscilloscope. Defibrillation was con-
firmed by palpation of the femoral pulse and QRS complexes 
in the electrocardiogram. With return of consciousness, the 
animal was allowed to right itself. After a recovery 
period of about 2 min, the animal was refibrillated and 
defibrillation was attempted with a voltage setting 5-10 
percent less than that of the previous trial. This 
procedure was repeated until the animal was not de-
fibrillated by the first shock, and then a stronger shock 
was applied immediately to restore cardiac pumping action. 
Threshold voltage and current were defined as the lowest 
values able to defibrillate the ventricles. Only data 
from the first shock delivered after the onset of 
fibrillation were used in calculation of threshold. In 
this study threshold values were considered adequately pre-
cise if they differed no more than 10 percent from values 
unable to defibrillate the ventricles. Delivered energy 
and charge were calculated as described by Babbs and 
Whistler (1978). 
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Twenty minutes after the defibrillation threshold was 
determined in the unanesthetized animal, intravenous pento-
barbital sodium (25-30 mg/kg), was given to produce 
surgical anesthesia and the defibrillation threshold 
measurement was repeated with the animal in dorsal recum-
bency. After a three-day recovery period, another set of 
threshold determinations was made in the awake and 
anesthetized states. 
On the final day of testing the defibrillation threshold 
was determined following larger doses of pentobarbital. 
After the routine threshold determination under surgical 
anesthesia, sufficient intravenous pentobarbital was given to 
produce apnea and the threshold measurement repeated. Then 
sufficient intravenous pentobarbital was given to produce 
circulatory shock (defined as systolic blood pressure less 
than 50 mmHg measured via a catheter placed in the abdominal 
aorta) and a final threshold determination made within 10 
minutes. During apnea and shock the animal was maintained 
using mechanical ventilation sufficient to produce a 
respiratory minute volume, measured with a Wright 
respirometer, roughly equal to that measured under surgical 
anesthesia. 
Results 
In all 5 dogs comparisons could be made between 
defibrillation thresholds in the awake and the anesthetized 
51 
states. In one dog, three successive comparisons of 
awake versus anesthetized threshold values were made during 
a twelve-day period. Threshold current data for this animal 
are plotted in Figure 2-1. The ratios of the threshold peak 
current for all dogs at all levels of anesthesia to the 
average threshold under surgical anesthesia for each animal 
are plotted in Figure 2-2. No consistent effect of pento-
barbital anesthesia on the ventricular defibrillation 
threshold is evident. The slight do~vnward trend in Figure 
2-2 is not statistically significant. 
Mean values of threshold shock strength, in terms of 
peak current, and delivered energy per 
kilogram body weight, are given in Table 2-1. One-way 
analyses of variance indicate that the observed effects of 
anesthesia level upon threshold current, and energy 
are far from statistically significant, as indicated by 
the p values in the table. 
The response of unanesthetized dogs to the fibrillation-
defibrillation procedure is worthy of mention. Typically, 
the dogs were not alarmed by the intracardiac electrical 
stimulation used to induce fibrillation. The loss of 
cerebral blood flow due to ventricular fibrillation produced 
initial excitation, lasting 5-15 sec, which rapidly 
diminished as the animal lost consciousness. Delivery of 
defibrillating current caused a brief, forceful contraction 
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Figure 2-1. Threshold peak current for ventricular de-
fibrillation in unanesthetized and anesthetized 
states on successive trials in the same animal. On 
three successive trials the threshold current in 
the unanesthetized animal was greater than, equal 
to, and less than the threshold current after 
induction of pentobarbital anesthesia. Mean 
threshold before anesthesia = 1.02 A/kg~ mean 
threshold after anesthesia = 1.08 A/kg. Threshold 
data for the unanesthetized dog were reproducible 





































Figure 2-2. Relative values of threshold peak current for ventricular defibrillation 
at four levels of anesthesia. Awake = no anesthesia, Surgical anesthesia = 
spontaneous respiration but no response to surgical stimulation (25-30 
mg/kg pentobarbital), Apnea = no spontaneous respiration (42-51 mg/kg 
pentobarbital, cumulative dose), Shock = aortic blood pressure less than 50 
mmHg systolic (61-77 mg/kg pentobarbital, cumulative dose). Mean threshold 
current under surgical anesthesia = 1.0 for each animal. Dog 1, solid 
circles; Dog 2, solid triangles; Dog 3, open circles; Dog 4, open squares; 
Dog 5, crosses. Ul w 































vocalization. Animals for whom the total circulatory arrest 
time was less than 30 sec rapidly regained consciousness, 
and resumed a sitting or standing position. Animals for 
whom the total circulatory arrest time was 30-60 sec did not 
regain consciousness as soon after defibrillation. These 
animals remained in dorsal recombency after resuscitation and 
appeared dazed or tranquilized. 
Conclusion 
The data indicate that defibrillation threshold is 
negligibly affected by the induction of anesthesia with 
pentobarbital sodium. Hence this anesthetic was selected 
for use in further defibrillation studies. 
Stabilitv and Precision of Control Data 
The question of the stability and reproducibility of 
control data is especially pertinent because of the intrinsic 
nature of the defibrillation studies in which the experimental 
animal literally is rescued from impending death on repeated 
occasions. Each fibrillation-defibrillation sequence rep-
resents a stress to the animal subject, including transient 
circulatory arrest, possible tissue hypoxia and acidosis, 
and the electric shock itself, any of which might effect 
the measured defibrillation threshold. 
Accordingly, the following studies were undertaken to 
determine (l) to what extent defibrillation threshold is 
stable and reproducible with time in pentobarbital 
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anesthetized dogs and (2) to what extent the stability of 
the baseline threshold level is dependent upon the recovery 
interval between threshold measurements. 
Method 
Fifteen mongrel dogs of both sexes, weighing 4 to 16 kg 
and anesthetized with pentobarbital sodium (30 mg/kg, i.v.), 
served as subjects. No other drugs except 0.9 percent saline 
were administered at any time. The trachea of each dog was 
intubated and the animal placed in dorsal recumbency for 
the duration of the study. The urinary bladder was 
catheterized with a #8 French filiform catheter connected 
to a closed volumetric drainage bottle. Aortic blood 
pressure was recorded using a P23DB Statham transducer. 
Respiratory minute volume was measured with a Wright 





monitored using an Instrumentation Laboratories Model 213 
blood-gas analyzer. Disk electrodes, 8, lO,or 12 em in 
diameter were applied to the shaved skin of the right and 
left hemithoraces with electrolytic jelly and sutured in 
place. The diameter of the electrodes was standardized to 
20 percent of the chest circumference, measured at the 
mid-sternal level. One electrode was centered over the 
apex beat area and the other at a corresponding position 
on the right chest wall, 3 em cephalad of the left 
electrode. 
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Mean aortic blood pressure, respiratory minute volume, 
urine output, arterial blood gases, and esophageal tempera-
ture were recorded at half hour intervals. A stable level 
of surgical anesthesia was maintained in each animal by 
intravenous doses of pentobarbital sodium 2-5 mg/kg each 
hour. Saline solution,0.9 percent, was given at a rate of 
1-2 ml/kg/hr by vein to maintain hydration. Esophageal 
temperature was maintained in the range of 36-39°C with the 
aid of warm overhead lights. 
Ventricular fibrillation was initiated by 2-10 volt 
60 Hz electrical stimulation of the right ventricle 
delivered via a bipolar electrode catheter inserted through 
the right jugular vein. The position of the electrode 
catheter in the right ventricle had been previously 
verified by recording the cardiac electrogram from the 
catheter electrodes. Ventricular fibrillation was confirmed 
by replacement of the QRS-T complexes of the electro-
cardiogram with random waves and the fall of aortic blood 
pressure toward zero. 
The output circuit of the damped sine wave defibrilla-
tor employed contained a capacitance of 16 ~F, an inductance 
of 44 mH, and an internal resistance of 7 ohms, as determined 
by the method of Babbs and Whistler(l978). The voltage on 
the capacitor could be varied continuously from 0 to 8000 
volts. The maximum stored energy available was 512 joules. 
A 1.00 ohm, 100 watt resistor in series with one electrode 
was used for measuring the current. 
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In a typical trial a defibrillator shock calculated 
to be adequate for defibrillation on the basis of the dog's 
body weight was delivered at the time of end-expiration, 
less than 15 sec after the onset of fibrillation. The 
voltage across the electrodes and current passing through the 
subject were recorded on a Tektronix model D-11 dual-channel 
storage oscilloscope. Defibrillation was confirmed by re-
turn of pulsatile blood pressure and QRS complexes in the 
electrocardiogram. After restoration of aortic blood 
pressure to a stable level, the animal was refibrillated 
and defibrillation was attempted with a voltage setting 
approximately 10 percent less than that of the previous 
trial. This procedure was repeated until defibrillation 
was not achieved, whereupon a stronger shock was applied 
immediately to restore cardiac pumping action. At no 
time did fibrillation persist for more than 30 sec. 
Threshold voltage and current were defined as the 
lowest values able to defibrillate the ventricles. In this 
study threshold values were considered adequately precise 
if peak current differed no more than 10 percent from a 
value unable to defibrillate the ventricles. Only data 
from the first shock delivered after the onset of fibrilla-
tion were used in calculations of threshold. Delivered energy 
was calculated as described previously (Babbs and v7histler, 19 78) . 
Three series of five dogs were studied. In Series l, 
threshold was measured every hour for 8 hours. In Series 2, 
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threshold was measured every 15 min for 5 hours. In Series 
3, threshold was measured every 5 min for 1 hour. This 
last series represents the closest spacing of threshold 
measurements consistently possible when only first-shock 
data are acceptable. 
Results 
The stability of ventricular defibrillation threshold is 
demonstrated by Figures 2-3 and 2-4, which present mean 
threshold current and energy ratios as a function of time, 
for animals in all three series. The threshold current 
and energy ratios were calculated by dividing the individual 
threshold values by the average of the first three "baseline" 
threshold values obtained for each animal. Hence the 
threshold energy and current ratios may be interpreted as 
the relative values obtained in experiments in which each 
animal served as its own control. 
Threshold peak current remained stable in all three 
series. Decreasing the recovery interval between threshold 
measurements from 60 to 15 to 5 minutes did not cause a 
discernible upward or dO"ivnward drift of threshold current. 
Threshold current stability was further assessed by 
computing the linear regression function relating the 
threshold current dose to time for each animal. The slopes 
of the regression lines so obtained give sensitive 
estimates of the overall rate of change of threshold current 
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Figure 2-3. Stability of defibrillation threshold current. 
Data points represent mean values of the threshold 
current ratio for the 5 dogs in each series at 
various times after the first fibrillation-defibrilla-
tion trial. Average baseline values of threshold 
current (1.00 on the vertical axis) were 1.40 
amp/kg for Series 1, threshold interval = 60 min; 
1.10 amp/kg for Series 2, threshold interval= 15 
min; and 1.13 amp/kg for Series 3, threshold interval 
= 5 min. The baseline values are not statistically 
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Figure 2-4. Stability of defibrillation threshold energy. 
Data points indicate mean values of the threshold 
energy ratio for the 5 dogs in each series at 
various times after the first fibrillation-defibrilla-
tion trial. Average baseline values of threshold 
energy (1.00 on the vertical axis) were 1.23 joules/kg 
for Series 1, threshold interval= 60 min; 0.87 
joules/kg for Series 2 threshold interval = 15 
min; and 1.06 joules/kg for Series 3, threshold 
interval = 5 min. The values are not statistically 
different (F = 2.34, p = 0.14). The time scale is 
logarithmic. 
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with time. The slopes were positive for 7 of 15 dogs, 
negative for 8 of 15 dogs, and not significantly different 
from zero (mean slope -0.008 amp/kg/hr, n=lS, Student's 
t=0.69, p=O.SO). 
Threshold delivered energy data were more variable 
than the current data and appeared to drift slightly down-
ward during the first hour. In all three series, defibrilla-
tion threshold energy after one hour was about 10 percent 
less than the initial threshold energy. The observed 
decrease in threshold energy was associated with a corres-
ponding decrease in transchest electrical impedence, cal-
culated by dividing peak voltage by peak current (Figure 
2-5) . 
Arterial blood pH, pco2 , and po2 remained stable in 
all control series, averaging 7.38, 34 mmHg, and 72 mmHg 
respectively. To evaluate subtle changes in blood-gas values 
during the course of experimentation, linear regression 
functions relating pH, pco
2
, and po 2 values to time were 
computed for each animal. The mean regression co-
efficients for each series are presented in Table 2-2. 
One-way analyses of variance reveal no significant differen-
ces in the regression coefficients for the three experimental 
groups, indicating that increasing the frequency of 
threshold measurements from 1 to 12 per hour did not cause 
a deterioration in arterial blood gas status. The observed 
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Figure 2-5. Stability of transchest electrical impedance. 
Data points represent mean values of the ratio Z/~ 
of transchest impedance, z, at various times after0 
the first fibrillation-defibrillation trial to the 
initial impedance value, Z0 , at time zero. The 
apparent impedance Z, in ohms between the defibrilla-
ting electrodes was calculated as peak voltage/peak 
current for shocks delivered at the time of end 
expiration. Absolute values of Z0 for the three 
series of dogs were 57 ohms for Series 1~ 60 ohms 
for Series 2; and 52 ohms for Series 3. These 
values are not statistically different (F = 0.72, 
p = 0.51). 











Regression coefficients a 0 and al of equations of best fit of the form 
y=a0 +a1t are presented as ''initial" values and "rate of change" for 
blood gas variables y=pH, pC02, or p02 as a function of time, t. 
Coefficients a 0 and a1 were computed for each animal. Table entries 
represent the mean values of the coefficients for the animals in each 
series. 
The F ratios for one-way analyses of variance and associated p values 
test the null hypotheses that the coefficients for the three series 
are the same. The Student's t statistics and associated p values test 
the null hypotheses that the mean values of the regression coefficients 
a1 are zero for the population of all 15 animals. The regression co-
efficients for the three series are not significantly different, and the 
coefficients, a 1 , are not significantly different from zero. 
Threshold I pH pco2 p02 
Interval Initial Rate of _1 
Initial' Rate of Initial ~ Rate of 
(min) Change(hr ) (mmHg) Change (mmHg) Change 
(mmHg/hr) (mmHg/hr) 
60 7.37 -0.003 35 -0.2 
15 7.38 0.006 34 0.1 
5 7.39 -0.03 34 I -6.3 
7.38 -0.007 34 -1.8 
0.31 3.27 0.04 ' 2.40 
0.74 0.09 0.96 0.15 
!Student' sl -1.29 -1.26 
t I I . 
I p I 0.22 I 0.98 I. I 





indicated by the slopes of the linear regression functions, 
were not statistically different from zero. 
The precision of defibrillation threshold data may be 
appreciated with reference to Figure 2-6, which illus-
trates the frequency distributions of the 209 threshold 
energy and current ratios obtained in all three series. The 
distributions of the three series were pooled since all 
have means of 0.97-0.99 and variances which are not sig-
nificantly different (Bartlett's 2 0.20, 0.90 for X = p = 
current; Bartlett's x2 = 2 o 841 p = 0.24 for energy). These 
histograms illustrate the relative dispersion of threshold 
data about the baseline established for each animal at the 
beginning of each experiment. The standard deviations of 
the distributions are a measure of the reproducibility of 
the threshold data. Under control conditions the precision 
of threshold current data is greater than the precision of 
threshold energy data. 
Discussion 
In the absence of pharmacologic or pathologic inter-
vention, the threshold current for ventricular defibrilla-
tion remains stable in pentobarbital anesthetized dogs. 
Even though the animal is repeatedly rescued from impending 
death, there appears to be no cumulative influence of re-
peated trials of fibrillation and defibrillation upon the 
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Figure 2-6. Histograms of threshold current and energy 
ratios obtained in 15 control dogs. The width of 
each class interval is 0.05. The value 1.00 on 
the horizontal axes represents the average of the 
first three threshold values obtained for each 
animal. Variance represented by the histograms 
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therefore reflects only variability nf individual 
subjects. The standard deviation of the threshold current 
distribution is 11 percent of the mean. The standard 
deviation of the threshold energy distribution is 22 
percent of the mean. 
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fibrillation is permitted on any trial. This conclusion 
is valid even if threshold is measured as frequently as 
every five min, under which circumstances there is loss of 
pulsatile blood pressure for 10-20 percent of the elapsed 
time. This stability in threshold current is associated 
with comparable stability in the arterial blood pH, pco
2
, 
and po2 . 
The approximate 10 percent decrease in threshold 
delivered energy during the first hour of testing is 
associated with a corresponding decrease of the apparent 
impedance between the defibrillating electrodes. Geddes 
(1975) and Chambers (1978) have reported similar decreases 
in transthoracic impedance during successive ventricular 
defibrillation trials in animals and in man. These reports 
imply that the critical variable associated with decreasing 
impedance is the number of fibrillation-defibrillation 
trials. In our studies, however, time appears to be a 
better predictor of subject impedance than trial number. 
The decrease in transchest impedance during the first hour 
of testing averaged 4.64 ohms/hour for the dogs of Series 
1 and 5.21 ohms/hour for the dogs of Series 3. These 
values are not statistically different (Student's t = -0.28, 
p = 0.79) even though threshold was obtained 12 times in 
Series 3 and only 2 times in Series 1. Accordingly factors 
other than the number of fibrillation-defibrillation 
trials, such as impregnation of high resistivity skin with 
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electrolytic jelly, may be responsible for the slight initial 
fall in transchest impedance and threshold energy. 
Using the method described in this thesis, defibrilla-
tion threshold current may be measured with a precision of 
~ 10.9 percent of the mean, as indicated by the standard 
deviation of a large population of repeated threshold 
measurements in stable animal preparations. The comparable 
precision of threshold energy measurements is~ 21.8 percent 
of the mean. The two-fold greater uncertainty in threshold 
energy is a direct result of the fact that delivered energy 
is proportional to the square of the peak current. As 
reported in detail elsewhere (Babbs and Whistler, 1978), 
the energy, W, delivered by a damped sine wave defibrillator 
may be calculated from the peak current, I, by an expression 
2 of the form N = ai , where the factor, a, contains terms 
relating to the internal resistance, inductance, and 
capacitance of the defibrillator and the transchest impedance 
of the subject. Hm...,ever, if"a"is taken as a simple 
constant, all of the observed variance in threshold energy, 
W, may be explained. Consider Gaussian random variable, I 1 
with mean value, mi, and standard deviation 
for any constant, a, then 
0 02 
I 2 I + 4 
mi 2 ow mi 
= 
~ 2 oi 




2 If W = ai 
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For the special case cri;mi << 1, indicating relatively 
small variations in I, crw/~~ z2cri/mi. If I is taken as 
the threshold current ratio in defibrillation experiments 
one would therefore expect 
ow - 2 0.107 = 0.217 
row 0.984 
The observed uncertainty, crw/~, in the threshold energy 
ratio was 0.218. Thus the greater uncertainty of threshold 
energy, compared to threshold current, may be explained by 
the necessary mathematical relationship between energy and 
current. The slight decrease in transchest impedance which 
was observed does not contribute significantly to the 
variability in threshold energy data. 
One additional factor which may be quantitated at this 
time contributes to the variability in defibrillation 
threshold data. Some of the variability in measured 
threshold values is due to the method of threshold determina-
tion in which discrete current values differing by 
approximately 10 percent are tested, rather than due to 
variation in the animal's true threshold. In a discussion 
of the precision of defibrillation threshold data, it is 
worthwhile to identify the magnitude of this sampling variance 
in order to assess how much of the observed variance in 
threshold data is due to the experimental animal and how 
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much of the observed variance is due to the experimental 
protocol. 
Suppose the true, physiologic value of the defibrilla-
tion threshold current remained absolutely constant at a 
value I and that the distribution of measured thresholds 
0 
shown in Figure 2-7 is uniform within the interval I 
0 
l.li . This distribution of measured thresholds would occur 
() 
if the first suprathreshold shock tested were selected 
"blindly" with no fixed relation to the true threshold, a 
situation which exists in practice. In this case, the 
mean measured threshold would overestimate the true 
threshold by 5 percent, and the variance of the distribution 
of measured thresholds may be calculated analytically as: 
2 






2 di - ( 1. 0 5 I ) 2 
0 
= 0.00083 I 
2 
0 
Since the mean of the measured values overestimates true 
threshold by 5 percent (MI = 1.05 I
0
), one may express the 
sampling variance in terms of the mean measured threshold 
as 
2 
a 1' samp 1ng = 0.00076 M 
2 
I 
or a l' = 0.027MI . samp 1ng 
Further, since sampling and physiologic variance are 
independent phenomena,* the physiologic variance in 
* That is, the variability of the experimenter and the 
variability of the animal are not correlated. 
-1 l- 2CJ 
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Figure 2-7. Uniform distribution of measured threshold 
currents expected if physiologic variance were 
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zero. Probability density is scaled such that the 
total area under the distribution function is unity. 
For a given experiment of n observations, the 
expected number of observations in class interval, 
I + (~ I)/2, would be n f(I) ~I. 
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defibrillation threshold current may be estimated as: 
2 2 2 2 2 
a h . l . =a b d-a 1 . =0.01188M1 -0.00076MI p ys1o og1c o serve samp 1ng 
= 0. 01112~-ii 
and 
aphysiologic = O.lOSMI · 
That is, if only physiologic variation were present, the 
standard deviation of measured threshold currents would 
be 10.5 percent of the mean. This figure is hardly 
different from the 10.9 percent standard deviation ob-
served using the method described in this thesis. The 
sampling variance introduced by testing discrete defibrilla-
tor currents differing by 10 percent in amplitude is 
negligible compared to the physiologic variance. Therefore 
there appears to be little justification for testing de-
fibrillator currents differing by less than 10 percent in 
the routine measurement of defibrillation threshold. 
In summary,these studies show repeated fibrillation and 
defibrillation are well tolerated by pentobarbital-
anesthetized dogs which fibrillate for less than 30 sec. 
The experimental manipulations inherent in defibrillation 
studies as described in this thesis do not in themselves 
alter the phenomena under investigation. The precision of 
threshold data obtained by the method reported here is 
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limited only by physiologic variability of the animal subject 
and, in the case of threshold energy, by the mathematical 
relationship of energy to current. Accordingly the pento-
barbital anesthetized dog, prepared as described in this 
chapter, is a suitable model for pharmacologic studies of 
ventricular defibrillation. 
CHAPTER 3 
ALTERATION OF VENTRICULAR DEFIBRILLATION 
THRESHOLD BY DRUG TREATMENT 
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This phase of the investigation was conducted to 
determine if selected cardiac drugs which in theory alter 
the ventricular defibrillation threshold produce the 
anticipated effects in the intact animal. 
Treatments Which Alter Sodium and 
Potassium Conductance 
The following studies were conducted to determine the 
effect on ventricular defibrillation threshold of quinidine, 
which acts primarily by decreasing sodium conductance, and 
of lidocaine, which acts primarily by increasing potassium 
conductance. These ionic mechanisms of action are anti-
cipated to cause an increase in defibrillation threshold. 
Method 
Twenty pentobarbital anesthetized mongrel dogs served 
as subjects. This anesthetic was chosen because it does 
not alter the defibrillation threshold. Details of the 
anesthesia and monitoring have been described in Chapter 2. 
In brief, threshold was determined by repeated trials of 
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fibrillation and transchest defibrillation, each with a 
damped sinusoidal defibrillator shock of peak current 
amplitude 10 percent less than the amplitude of the pre-
ceding shock. The lowest intensity shock able to achieve 
defibrillation, and differing no more than 10 percent in 
amplitude from a shock which did not defibrillate, was de-
fined as threshold. 
The animals were never permitted to fibrillate more 
than 30 sec prior to defibrillation and never refibrillated 
until arterial blood pressure had returned to a stable level. 
The peak voltage and peak current for each shock were re-
corded on a storage oscilloscope. Only data from the first 
shocks applied after the onset of ventricular fibrillation 
were used in the calculation of threshold. Delivered 
energy was calculated as described by Babbs and Whistler 
(1978). 
The antiarrhythmic drugs used in this study were 
quinidine gluconate, injection, U.S.P. (Lilly), 80 mg/ml 
in water vehicle, and lidocaine hydrochloride (Astra), 
20 mg/ml, in a water vehicle, pH 6-7. Quinidine was given 
as a single intravenous bolus (50 mg/kg) to 5 dogs. Lido-
caine was given as an intravenous bolus (3 mg/kg) to 5 
dogs and as a constant infusion (0.5 mg/kg/min) to another 
5 dogs. The 5 dogs in the control group received no drug 
other than pentobarbital. Ventricular defibrillation 
threshold was determined at 15 min intervals. Three 
76 
pre-drug control threshold determinations served to 
establish a stable baseline for each animal. The mean of 
the first three threshold values was defined as 100 percent 
of control and served as the reference for drug effect in 
each animal. Drug induced changes in the ECG were also noted. 
Results 
Figure 3-1 shows the dramatic elevation of the threshold 
current and energy caused by an intravenous bolus of 
quinidine gluconate (50 mg quinidine/kg) in 5 dogs. 
The data points in Figure 3-1 represent mean threshold 
energy and current ratios. The threshold energy and 
current ratios were calculated by dividing the individual 
threshold values by the average of the first three ''baseline" 
threshold values for each animal. The period of negative 
time on the abscissa represents this baseline. Threshold 
peak current was increased by 70 percent and threshold 
delivered energy was increased by 172 percent by 50 mg/kg 
of intravenous quinidine gluconate. This dose was sufficient 
to cause systolic blood pressure to fall initially from 170 
to 95 mmHg, and diastolic blood pressure to fall initially 
from 128 to 60 mmHg. Thereafter the magnitude of blood 
pressure depression gradually diminished at approximately 
the same rate as the magnitude of defibrillation threshold 
elevation. 
Figure 3-2 illustrates a similar elevation of de-
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Figure 3-1. Effect of intravenous quinidine on ventricular 
defibrillation threshold in 5 dogs. All threshold 
elevations after quinidine injection are statistically 
significant (U < 11, p < 0.01) except the final data 
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Figure 3-2. Effect of intravenous lidocaine on ventricular 
defibrillation threshold in 5 dogs. The peak eleva-
tion in defibrillation threshold is statistically 
significant (U < 11, p < 0.01). 
79 
in a dose of 3 mg/kg. The maximal elevation of threshold 
current was 26 percent and the maximal elevation of 
threshold energy was 48 percent. In contrast to the 
threshold elevation observed after intravenous quinidine, 
the effect of lidocaine appeared slower in onset. 
Administration of lidocaine by continuous intravenous in-
fusion (0.5 mg/kg/min) also caused threshold to rise 
continuously in another group of 5 dogs (Figure 3-3) to a 
maximum of 199 percent of control energy and 145 percent of 
control current after 80 min. Mean blood pressure fell 
from 150 mmHg at the beginning to 110 mmHg at the end of 
the lidocaine infusion. 
Figure 3-4 illustrates mean threshold energy and 
current in the control animals which received no drug other 
than pentobarbital anesthesia. These animals were studied 
for a longer period of time than any drug treatment group. 
In control animals, threshold energy decreased by about 10 
percent during the first hour of testing and thereafter 
remained stable. Mean threshold current did not change 
over a period of 280 minutes. 
Discussion 
Elevation of ventricular defibrillation threshold by 
quinidine and lidocaine confirms the predictions of the 
theory of defibrillation presented in Chapter 1. The scheme 
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Figure 3~3. Effect of lidocaine infusion on ventricular 
defibrillation threshold. All threshold elevations 
after onset of the infusion are statistically sig-
nificant (U < 14, p < 0.05). After 30 min of 
infusion threshold elevations are highly significant 
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Figure 3-4. Effect of pentobarbital anesthesia only on 
ventricular defibrillation threshold in 5 dogs. 
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These animals served as controls. The slight, periodic 
variations in these threshold data were not reproduci-
ble in other control series. 
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will have two effects: first, a slight negative shift of the 
resting membrane potential, and second, a positive shift 
of the transmembrane potential at which the depolarizing 
sodium current exceeds the hyperpolarizing potassium current 
and generates Phase 0. As a result the theory predicts 
that any agent which decreases sodium conductance would cause 
a greater voltage gap between membrane resting and firing 
potentialswhich must be overcome by the action of de-
fibrillating current. In fact, quinidine, a drug which 
decreases sodium conductance, did increase the electric 
current "dose" for defibrillation. Lidocaine, however, 
acts by increasing potassium conductance at therapeutic 
doses. The theory of Chapter 1 predicts that increased 
potassium conductance would decrease the resting membrane 
potential slightly and raise the firing threshold at which 
inward sodium current exceeds outward potassium current. 
In turn, defibrillation threshold would be expected to 
increase. This prediction, too, was confirmed by the 
experimental results. Hence the threshold elevation caused 
by antiarrhythmic drugs which alter sodium or potassium 
conductance can be understood in terms of the principles of 
membrane physiology. 
The notion that quinidine and lidocaine acted by 
different mechanisms to raise defibrillation threshold 
in the present studies is confirmed by the electrocardio-
graphic data. In theory, decreased transmembrane sodium 
83 
conductance is related to decreased (dV/dt)
0 
and in turn to 
prolonged QRS complex duration, as explained in Chapter 1. 
Lidocaine in higher concentrations is known to have such 
a quinidine-like effect (deJong, 1970; Mandel and Bigger, 
1971; Weld and Bigger, 1973). However in the present 
study quinidine prolonged the QRS complex duration while 
lidocaine did not. Following quinidine (50 mg/kg, i.v.), 
the mean duration of the QRS complex increased 37 percent 
and then gradually returned to the control level. The 
mean percent increase in QRS duration was correlated with 
the mean percent increase in defibrillation threshold 
2 current (r =0.67, p=0.004), In lidocaine-treated animals, 
however, QRS duration remained essentially constant, and 
changes in mean QRS duration were not correlated with 
changes in mean defibrillation threshold current 
2 (r =0.06, p=0.46). These findings are consistent with 
the claim that the effect of lidocaine was produced by a 
different ionic mechanism than that of quinidine. 
Treatments Which Alter the Potassium 
Equilibrium Potential (EKl 
Theory predicts that the defibrillation threshold will 
not only be altered by changes in the sodium or potassium 
conductance of the membrane but also by parallel shifts in 
the IK versus Em function of Figure l-6(a), caused by 
changes in the potassium equilibrium potential. The 
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objectives of the studies reported in this section were as 
follows: 
e To investigate changes in ventricular defibrillation 
threshold produced by changes in extracellular potassium 
ion concentration (K ) in dogs. 
0 
e To hold total body potassium content essentially 
constant during the above studies. 
• To measure the intracellular potassium ion concentration 
(K.) of the ventricular myocardium. 
1 
• To plot defibrillation threshold as a function of 




Healthy mongrel dogs weighing 17-20 kilograms served 
as subjects. Anesthesia was induced with intravenous 
pentobarbital sodium (25-30 mg/kg) and maintained with 
additional 2 mg/kg boluses as necessary. No other drug 
except potassium chloride was administered. Esophageal 
temperature, the electrocardiogram, aortic blood pressure, 
respiratory minute volume, and arterial blood pH, pco2 , 
and po2 were monitored as described in Chapter 2. One 
hour before the beginning of defibrillation threshold 
measurements, the right and left ureters were ligated 
through a midline laparotomy and the wound closed with 
continuous suture. A bipolar catheter electrode was 
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placed in the right ventricle via a jugular venous cut-down 
to initiate ventricular fibrillation. 
Defibrillation threshold was determined three times 
during the 120 min period before potassium administration 
and three times during the 120 min period after potassium 
administration. Plasma levels of sodium and potassium in 
arterial blood were monitored at 10-20 min intervals using 
an Instrumentation Laboratories Model 443 flame photometer. 
After the first three pre-drug threshold determinations, 
intravenous potassium chloride in a dose of 1.0 mEq/kg 
was given slowly over a period of 5-10 min as the electro-
cardiogram was closely monitored for arrhythmias. 
Following this injection, a slow infusion of potassium 
chloride at 0.01 mEq/kg/min was begun using a motor driven 
syringe. After stable, elevated levels of plasma 
potassium were attained, three more measurements of the 
defibrillation threshold were made during the 120 min 
following the onset of potassium administration. 
Measurement of Intracellular Potassium Concentration. 
Following completion of the defibrillation threshold 
measurements, the potassium infusion was stopped and median 
sternotomy and pericardiotomy were performed. The heart was 
perfused first with lactated Ringer's solution and then with 
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5 percent dextrose in water via a cannula placed in the 
left bracheocephalic artery. All other branches of the 
aortic arch except of the coronary arteries were ligated. 
Before perfusion, the cavae and descending thoracic aorta 
were clamped; the atria were cut to promote drainage of 
blood and perfusate. After perfusion with 500 ml of 
lactated Ringer's solution, a 1 gram sample of right 
ventricular muscle nourished by the left anterior descending 
coronary artery was excised for assay of sodium and 
potassium content. Then perfusion with 500 ml of dextrose 
solution was carried out and a 1 gram sample of right 
ventricular muscle nourished by the right coronary artery 
was excised for assay of tissue sodium and potassium content. 
The assay procedure employed overnight digestion of the 
tissue samples in 10 volumes of 1 molar H2so 4 at 80°C. 
Such digestion for 1 hour or longer produced maximal 
recovery of sodium and potassium from the pieces of myo-
cardium. Assay of the supernatant solution for sodium and 
potassium concentration was accomplished using an Instrumenta-
tion Laboratories Model 443 flame photometer, calibrated 





. f + d -+ . tlons o Na an K lons. Samples of coronary sinus 
effluent taken after perfusion with 400 ml of each solution 
provided a measure of extracellular sodium and potassium 
concentrations in each case. Perfusion pressure was always 
80-120 mmHg. 
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Calculation of the Fractional Extracellular Fluid Volume. 
Total tissue sodium concentration, Nat, is given by 
the expression 
= 0 Na + 0 .Na. 
0 0 l l 
where 0 = volume 
0 
fraction of the extracellular space 
0. = 1-0 = volume fraction of the intracellular space 
l 0 
Na. = intracellular sodium concentration 
l 
Na = extracellular sodium concentration. 
0 
Assuming that sodium ions cross intact cell membranes 
slowly, total tissue sodium is linearly related to extra-
cellular sodium concentration, with intracellular sodium 
remaining constant, when the tissue is perfused with iso-
tonic solutions of differing sodium concentrations. 





Nat(Ringer's) - Nat(dextrose) 
Na (Ringer's) Na (dextrose) 
0 0 
Calculation of Intracellular Potassium Concentration. 
Once 0 0 is known, intracellular potassium concentra-
tion is then calculated from total tissue and plasma 
potassium concentrations as 
K. = 
l 
Kt - 0. K 
0 0 
1 - 0 
0 
Investigation of Higher Levels of K . 
0 
The potassium treatment schedule for the 10 animals 
just described was designed to produce stable elevations 
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of extracellular potassium concentration near the maximal 
levels tolerated by the animals, without profound hypo-
tension, paralysis of the sinoatrial or atrioventricular 
nodes, or intractable tachyarrhythmias. 
In preliminary experiments such complications did occur 
with more rapid rates of potassium infusion. 
To elu6idate the influence of high concentrations 
of extracellular potassium upon defibrillation threshold, 
an experiment was designed to determine at what concentra-
tion of extracellular potassium the ventricles of dogs 
would spontaneously defibrillate, that is, at what level 
of K defibrillation threshold was zero. These studies 
0 
were carried out in open-chest dogs in whom cardiac output 
was maintained by a left ventricular bypass pump. The 
problem of circulatory collapse produced by very high 
levels of plasma potassium was thus obviated. No de-
fibrillator was needed for the study. Neither was it 
necessary to establish a control level of the defibrillation 
threshold, since zero threshold current is equivalent to 
zero percent of control in any case. 
Nine pentobarbital anesthetized dogs served as 
subjects for this study. After median sternotomy and 
pericardiotomy had been performed, surgical hemostasis 
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secured, and heparin (2 mg/kg i.v.), administered 
ventricular fibrillation was initiated by 60 Hz stimulation 
of the right ventricular surface. Each animal was 
immediately placed on a La Farge-type left ventricular 
bypass system. As shown in 
Figure 3-5, blood was withdrawn from the left ventricle 
through a large bore multiple side-hole cannula inserted 
through a small stab wound in the cardiac apex. Blood 
withdrawn from the left ventricle was led through a Travenol 
roller pump and reinfused into the animal via a large bore, 
right-angle cannula previously placed in the abdominal 
aorta. Prior to institution of the bypass, the tubing was 
filled with warmed (30-40°C) Ringer's solution. Care was 
taken to ensure that the left ventricular cannula was not 
pushed through the aortic valve from the left ventricle, 
since a short circuit would have been created. To promote 
venous return, the animal's hindquarters were elevated 
30 degrees and up to 1000 ml of additional Ringer's solution 
infused as necessary to maintain a stable artificial 
cardiac output. 
After the bypass system had been adjusted, potassium 
chloride was infused via the femoral vein at a rate of 
0.2 mEq/kg/min, calculated to raise the extracellular 
potassium concentration by approximately 1 mEq/L/min. 
Esophageal temperature, the electrocardiogram, arterial 














Figure 3-5. Principle of open-chest left ventricular 
bypass. The left ventricle, LV, is catheterized 
via a stab wound in the cardiac apex. The roller 
pump provides an artificial left ventricular 
output, which is returned to the abdominal aorta. 
The negative pressure created in the left ventricle 
and left atrium is sufficient to draw systemic 
venous blood through the pulmonary vasculature. 
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monitored as described in Chapter 2. Two arterial blood 
samples were taken at the time of spontaneous, chemical 
defibrillation for analysis of plasma potassium concentra-
tion. The first sample was taken at the moment fibrillation 
appeared to cease, as judged by the electrocardiogram and 
direct visual inspection of the heart. The second sample 
was taken when defibrillation was confirmed by electrical 
pacing of the ventricles by single 10 volt, 2 msec stimuli 
applied to the ventricular surface with hand-held bipolar 
electrodes. Generation of ventricular ectopic beats in 
the electrocardiogram was taken as confirmation of 
ventricular defibrillation. The average plasma potassium 
concentration of the first and second samples was taken as 
the level required for defibrillation with zero current 
and energy. 
Results 
The stable elevation of plasma potassium concentration 
produced by the "bolus plus infusion" technique in ten dogs 
is illustrated in Figure 3-6. The technique described 
produced a stable plateau of extracellular potassium 
concentration for defibrillation studies. The overall 
mean control potassium level was 3.9 mEq/L and the overall 
post potassium infusion level was 7.5 mEq/L. 
Calculated levels of intracellular potassium concentration 
in 4 of these animals and in 4 animals which did not re-
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Figure 3-6. Elevation of plasma potassium in 10 dogs 
produced by a slow intravenous injection of 
potassium chloride, 1.0 mEq/kg, followed by a 




The mean value for intracellular potassium was 91 mEq/1 
and the standard error of the mean was 3.6 mEq/1. 
Intracellular potassium concentrations of dogs which re-
ceived potassium treatment vrerenot significantly different 
from those of dogs which did not (t = 0.66, p = 0.53). 
Figure 3-7 surnmarizes the effects of increased extra-
cellular potassium concentration on ventricular defibrilla-
tion threshold. Defibrillation threshold as percent of 
control is plotted as a function of plasma potassium con-
centration and of calculated potassium equilibrium potential. 
The left-hand and middle data points represent mean control 
and post-potassium infusion threshold values. The right-
hand data point represents the mean plasma potassium 
concentration for spontaneous defibrillation with zero 
current or energy. The upper scale for potassium equilibrium 
potential was calculated from the Nernst equation using 
the mean value of intracellular potassium concentration 
reported in Table 3-1. As extracellular potassium concentra-
tion is increased, ventricular defibrillation threshold 
dramatically decreased, reaching zero value when K was 
0 
16.6 mEq/1 and EK was -46 mV. 
Discussion 
The theory developed in Chapter 1 predicts that the 
defibrillation threshold should be relat~d to the 
potassium equilibrium potential, EK. As EK is increased, 
the gap between the theoretical equilibria for resting 
Figure 3-7. Effect of elevated extracellular potassium 
concentration on ventricular defibrillation 
threshold in dogs. 
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Table 3-1. Ionic concentrations in canine ventricular muscle. 
cri=volume fraction of extracellular space; Nat=tissue 
sodium concentration; Kt=tissue potassium concentration; 
Nai=intracellular sodium concentration; Kj_=intra-
cellular potassium concentration. Prior KCl=KCl 1.0 















for 120 min. Student's t tests the null hypothesis 
that values for dogs 1-4 (no prior KCl) are equal to 
values for dogs 5-8 (prior KCl treatment) . Prior KCl 
did not cause significant changes in the tabulated 
values. 
Prior 0· Nat Kt Na. K. 1 l 1 KCl mEq/1 mEq/1 mEq/1 · mEg/1 
no 0.27 37 54 16 77 
no 0.26 45 82 15 109 
no 0.15 31 71 14 83 
no 0.20 36 69 11 85 
yes 0.26 40 75 7 99 
yes 0.18 29 73 6 88 
yes 0.17 34 76 17 90 
yes 0.24 40 74 8 97 
22 37 72 12 91 
4.7 5.2 8.1 4.3 10.2 
0.66 0.38 -0.95 1. 63 -0.66 
0.53 0.72 0.38 0.15 0.53 
tailed) 
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membrane potential and cellular-firing threshold narrows. 
This change in turn is predicted to decrease the de-
fibrillation threshold. At some value of EK less 
negative than normal,theory predicts that defibrillation 
threshold is zero. As indicated in Figure 3-7, the 
decrease in defibrillation threshold is in fact related 
to the increase in EK, and defibrillation threshold falls 
to zero at half the normal negative value of EK. Thus the 
influence upon defibrillation threshold of drugs which alter 
the potassium equilibrium potential may also be understood 
in terms of fundamental concepts of membrane physiology. 
Discussion of Drug Effects on Ventricular 
Defibrillation Threshold 
Drug effects on defibrillation threshold are of 
potential clinical importance because patients who fibrillate 
may have been placed on maintenance inotropic or anti-
arrhythmic drug therapy or admitted to coronary care units 
where antiarrhythmic drugs may be given routinely. Intra-
venous lidocaine by bolus injection or continuous infusion 
is currently recommended for hospitalized patients following 
acute myocardial infarction for suppression of ventricular 
arrhythmias (Hurst, 1974; Rawlings, 1976). Nonetheless, 
patients receiving lidocaine may still fibrillate (Pantridge, 
1975) . A variety of drugs may be given prior to defibrilla-
tion in attempts at cardiopulmonary resuscitation. Since 
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some authors have indicated that present commercial 
defibrillators, which store 400 joules of energy, may 
have marginal or inadequate output for heavyweight 
patients (Tacker, 1974; Collins, 1978), the question of 
whether cardiac drugs alter the electrical shock strength 
required for defibrillation becomes especially pertinent. 
The present studies show that members of three classes 
of cardiac drugs alter the energy and current for electrical 
ventricular defibrillation. Quinidine, a drug which acts 
primarily by decreasing transmembrane sodium conductance, 
and lidocaine, a drug which acts primarily by increasing 
transmembrane potassium conductance, raise defibrillation 
threshold. Potassium chloride, a drug which acts by making 
potassium equilibrium potential less negative, lowers the 
defibrillation threshold. These findings significantly 
augment the literature concerning drug interactions with 
defibrillating current. 
The only previous report of the influence of anti-
arrhythmic drugs upon ventricular defibrillation threshold 
is that of Woolfolk (1966), who found that quinidine 
(10-60 mg/kg, i.v.) decreased the likelihood of successful 
ventricular defibrillation in dogs given transchest shocks 
of 30, 40, or 50 joules. The present studies confirm 
Woolfolk's conclusion and also demonstrate that failure to 
defibrillate in the presence of quinidine may be reversed 
by the use of increased electric shock strength. 
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Lown (1968) reported that the mean stored energy for 
ventricular defibrillation by damped sinusoidal current in 
5 dogs, given toxic doses of acetyl strophanthidin and 
ouabain, was 42 joules compared to the pre-drug value of 
58 joules. In this study, digitalis glycosides appeared 
to decrease defibrillation threshold by 27 percent, although 
the difference was not statistically significant. Lown's 
data were obtained in animals given digitalis glycosides 
in doses sufficient to produce ventricular tachycardia. 
Fibrillation was produced by transthoracic direct current 
shocks delivered during the "vulnerable period" of the 
cardiac cycle. The post-defibrillation rhythm was always 
ventricular tachycardia, not sinus rhythm. However, when 
ventricular fibrillation was caused by higher doses of 
digitalis in three of these animals, the arrhythmia could 
not be reverted, even by multiple,high energy shocks. 
Tacker (1975) found a dose-related decrease in de-
fibrillation threshold current and energy in dogs following 
a single intravenous dose of ouabain. A dose of 50 vg/kg, 
corresponding to that used in Lown's study, produced an 
average maximum decrease in threshold energy of 29 percent, 
a finding virtually identical to that of Lown. However, 
at a higher dose, 80 vg/kg, Tacker reported that the lethal 
mechanism in 2 of 4 dogs was electromechanical dissociation 
following successful defibrillation rather than failure to 
defibrillate. Both studies, how·ever, agree that high, 
99 
but not lethal, doses of ouabain decrease the defibrilla-
tion threshold. 
These findings are consistent with the effects of 
potassium reported in this thesis and may be explained as 
an indirect effect of the well-known inhibition of 
membrane-bound sodium/potassium ATPase by digitalis 
glycosides. This cellular effect of digitalis preparations 
causes inhibition of active transport of sodium ions out of 
and potassium ions into myocardial cells. As a result, 
there is a net outward leakage of potassium ions (Langer 
and Serena, 1970) which conceivably could produce local 
elevations in extracellular potassium concentration with 
resultant depression of the defibrillation threshold. 
These indirect alterations in defibrillation threshold 
by induced changes in local extracellular potassium concen-
tration may also explain the recent (unpublished) observa-
tion in our laboratories that defibrillation threshold 
decreases following durations of fibrillation and total 
circulatory arrest lasting more than 2 min. In addition 
to depression of defibrillation threshold, we have found 
in preliminary experiments that the potassium concentration 
of blood recovered from the coronary vascular bed increases 
progressively as the duration of fibrillation and cardiac 
anoxia is lengthened. Such hearts, which have fibrillated 
for more than 2 min exhibit hypocontractility following 
defibrillation which may be reversed by calcium 
administration or several minutes of cardiac massage 
and ventilation ("washing out" of the coronary vascular 
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bed) . These preliminary observations lead to the hypothesis 
that accumulation of extracellular potassium ions may lead 
to depression of both defibrillation threshold and post-de-
fibrillation cardiac contractility after prolonged durations 
of fibrillation. Hence, although elevations of extracellular 
potassium concentration as great as those reported in the 
present studies would never be produced for therapeutic 
reasons, the finding of threshold depression by potassium 
may be important in understanding various pathophysiologic 
states. 
Koning and associates (1973) have reported calcium 
and magnesium induced changes in the shock strength re-
quired for ventricular defibrillation using dog preparations 
in which the coronary circulation was maintained during 
fibrillation by means of a bypass pump. Using a unique 
double pulse technique, Koning found that after doubling 
the plasma calcium concentration, the second of two shocks 
delivered 5-10 msec apart must be increased in amplitude 
to achieve defibrillation. Doubling of plasma magnesium 
concentration caused the threshold amplitude of the second 
shock to decrease. These results may be analogous to an 
increase in the single shock defibrillation threshold by 
calcium and a decrease in the single shock defibrillation 
threshold by magnesium. Such an effect would be predicted 
by the theory developed in Chapter 1 to the extent that 
(1) calcium blocks sodium conductance and (2) magnesium 
acts as a calcium antagonist. 
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Although by no means a local anesthetic in most 
respects, calcium may have a local anesthetic-like action 
upon sodium conductance. Weidmann (1955) was the first to 
study the electrophysiologic properties of calcium in 
cardiac tissue. Using multiple microelectrodes in calf and 
sheep Purkinje fibers, this investigator found an increase 
in the cellular firing potential from -68 to -61 mV when 
extracellular calcium concentration was raised fourfold. 
However, since transmembrane resistance was unchanged or 
slightly decreased and since (dV/dt)
0 
was increased by 
added calcium, the author concluded that calcium does not 
decrease sodium conductance in the manner of local 
anesthetics. 
Such a "local anesthetic" effect of calcium ions, 
however, has been reported by others in both nerve and 
ventricular muscle. Frankenhaeuser and Hodgkin (19 57) 
studied voltage-clamped squid axons bathed by 0, 4, 22, 
and 112 mM Ga++ solutions made isotonic with choline and 
sodium salts. They found that increased extracellular 
calcium concentration decreased inward sodium current and 
transmembrane sodium conductance (gNa) . The curve relating 
gNa to transmembrane potential was shifted 15 mV to the 
right (less negative) by a fivefold increase in calcium 
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concentration. That is, 15 mV greater depolarization was 
required to produce a given gNa. Calcium, like local 
anesthetics or quinidine, also decreased potassium current 
and conductance. Unlike local anesthetics, however, calcium 
did not decrease the maximal sodium conductance. 
Beeler and Reuter (1970) developed a voltage-clamp 
method utilizing a sucrose gap and glass microelectrodes to 
study dog ventricular fiber bundles. Although these authors 
admitted some technical difficulties in measuring large 
inward sodium currents during Phase 0, they obtained curves 
relating peak transient (inward sodium) current to trans-
membrane potential (Em) similar to those for squid axon. 
In these studies, ventricular muscle activation curves for 
gNa were shifted in a parallel fashion toward less negative 
voltages by increased extracellular calcium concentration. 
The E for 50 percent of maximal activation of gNa was 
m 
shifted from -64 mv to -58 mV to -54 mV as extracellular 
calci urn was increased from 0. 2 mNl to 1. 8 mM to 7. 2 mM. To 
the extent that such a "local anesthetic" action of calcium 
occurred in Koning's defibrillation studies, his finding 
of increased second pulse amplitude for defibrillation in 
hypercalcemia is consistent with the studies reported in 
this thesis using quinidine, a drug which also decreases 
sodium conductance. 
Perhaps the most useful result of the present investiga-
tion is the development of a theory which relates 
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ventricular defibrillation threshold to four fundamental 
parameters of membrane physiology: gNa, gK, ENa' and EK. 
Such a theory readily suggests fruitful areas for further 
experimentation. These include both investigations of 
cardiac drugs known to alter gNa, gK, or both such as 
procaine amide, diphenylhydantoin, or propranolol, and 
investigations of pathophysiologic states which are known 
to increase potassium efflux from cells such as hypoxia 
(Singh, 1971/72; Lehr and Chau, 1973) or hypertension 
(Hochrein, 1971/72). These and similar studies, using the 
canine model described in this thesis, can be undertaken 
with confidence that the data obtained will be stable and 
reproducible and will demonstrate any true alterations in 
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